Children At-Risk For Hearing Impairment: A Retrospective Study Of The Ontario Infant Hearing Program Population by Smith, Katherine M.
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
12-12-2013 12:00 AM 
Children At-Risk For Hearing Impairment: A Retrospective Study 
Of The Ontario Infant Hearing Program Population 
Katherine M. Smith 
The University of Western Ontario 
Supervisor 
Dr. Susan Stanton 
The University of Western Ontario 
Graduate Program in Health and Rehabilitation Sciences 
A thesis submitted in partial fulfillment of the requirements for the degree in Master of Science 
© Katherine M. Smith 2013 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Health Policy Commons, and the Health Services Research Commons 
Recommended Citation 
Smith, Katherine M., "Children At-Risk For Hearing Impairment: A Retrospective Study Of The Ontario 
Infant Hearing Program Population" (2013). Electronic Thesis and Dissertation Repository. 1828. 
https://ir.lib.uwo.ca/etd/1828 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
   
CHILDREN AT-RISK FOR HEARING IMPAIRMENT: A RETROSPECTIVE 
STUDY OF THE ONTARIO INFANT HEARING PROGRAM POPULATION 
 
 
 
(Thesis format: Monograph) 
 
by 
 
Katherine Mary Smith 
 
 
Graduate Program in Health & Rehabilitation Sciences 
 
 
A thesis submitted in partial fulfillment  
of the requirements for the degree of  
Master of Science 
The School of Graduate and Postdoctoral Studies 
The University of Western Ontario 
London, Ontario, Canada 
 
 
 
© Katherine M. Smith (2013)
   
Abstract 
There is widespread agreement that infant hearing screening programs are effective 
but such programs may fail to detect all hearing impairment and children can develop 
subsequent hearing loss after passing the initial screen. This is the core rationale for 
surveillance programs that are analyzed in this thesis.  Infants with hearing risk factors are 
followed using surveillance programs that include monitoring by audiological assessment. 
The study population in this thesis consists of 2,390 children with normal hearing and 
248 children with hearing impairment from different referral routes. The Infant Hearing 
Program Surveillance group is 1.48% of the number of hearing-impaired children.  The thesis 
methodology identifies children with at least one risk factor and then analyzes the different 
referral routes and hearing loss features. It concludes that there is a need for further 
evaluation and improvements in surveillance programs, as well as all parts of screening and 
habilitation. 
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Chapter 1  
1 Introduction and Literature Review 
1.1 Introduction 
           Early Hearing Detection and Intervention (EHDI) programs for infants have been 
implemented with universal newborn hearing screening and treatment for congenital 
hearing loss in many developed countries.  As per Yoshinaga-Itano (2003), there is a 
critical period for early language development within the first six months of life.  This 
sensitive period derives from behavioral and neurological factors that can affect timelines 
for aspects of development, such as socio-emotional, auditory, speech, and language 
(Yoshinaga-Itano, 2004).  
Permanent childhood hearing impairmentin children affects the development of 
auditory speech perception, speech production, and English language acquisition 
(Yoshinaga-Itano, 2003).  Permanent childhood hearing impairment has prevalence rates 
of 1 to 2 per 1000 live births as defined by 40 decibels (moderate) or worse hearing loss 
in the better ear (Fortnum, 2003).  However, when mild hearing loss cases are included, 
with a definition of loss greater than 25 dB unilaterally, the prevalence is about 2-3/1000 
(Hyde, 2005).   The severity of hearing impairment varies and there are challenges in 
identifying some permanent childhood hearing impairments, such as progressive or late 
onset hearing loss (Hutt & Rhodes, 2008).   
Universal newborn hearing screening programs result in earlier diagnosis of 
hearing loss and early detection enables early intervention services for affected families 
(Yoshinaga-Itano, 2003).  It has been demonstrated that screening in hospitals results in 
identification of 75% of those with hearing impairment in the first three months of life 
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versus 75% identified by as late as 30 months in hospitals without screening (Yoshinaga-
Itano, 2003).  In previous generations, children were identified as late as two and a half 
years of age, after significant developmental opportunities have passed (Yoshinaga-Itano, 
2003).  
In the past decade, in most developed countries, early detection with universal 
infant hearing screening programs has made early intervention a priority, allowing health 
care professionals to immediately address the child’s communication developmental 
needs (Joint Committee on Infant Hearing, 2007).  Screening programs in general are 
considered ethically fitting in the presence of the appropriate procedures and resources 
available.  This enables timely access to confirmation of impairment, diagnosis, and 
intervention services that are considered effective, as specified by the World Health 
Organization (Wilson & Jungner, 1968).    
The current standard for EHDI programs is to complete the hearing screening in 
all infants by one month of age followed by audiological assessment by three months of 
age in those identified as at-risk for hearing loss based on the physiologic auditory 
screening outcome (e.g., otoacoustic emissions or automated auditory brainstem response 
testing); for those with confirmed hearing impairment, intervention should begin by six 
months of age (JCIH, 2007).   
Infants who pass newborn hearing screening but have one or more hearing risk 
factors, such as low birth weight, as listed in the Joint Committee on Infant Hearing 
(JCIH) 2007 guidelines, should have at least one diagnostic audiological assessment by 
24 to 30 months of age (JCIH, 2007).  Additionally, the JCIH recommends that all infants 
with certain risk factors for other speech or language impairments, like progressive or late 
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onset hearing loss, as well as auditory neural conduction disorders, such as auditory 
neuropathy spectrum disorders (ANSD), should be followed using surveillance programs 
for long-term communication development (JCIH, 2007).  These at-risk children are 
mandated to receive universal neonatal newborn hearing screening, and in addition, 
ongoing medical, speech and language, and audiological surveillance.  This is 
recommended as per the JCIH (2007) as a standard even if the child passes the newborn 
hearing screening protocol (JCIH, 2007).   
Improved outcomes for children with congenital hearing impairment are 
associated with confirmation and intervention by six months of age (Fortnum, 2003).  
Those infants who pass the initial infant screening with risk indicators for hard-to-detect 
impairments are considered especially susceptible.  While on-going monitoring is ideal, 
few EHDI programs have sufficient resources to implement comprehensive surveillance 
programs (JCIH, 2007).  This makes it difficult to evaluate the effectiveness of different 
surveillance and assessment protocols for difficult-to-detect hearing impairments, 
including ANSD and progressive, acquired, or delayed-onset hearing loss.  In addition, 
there is a need for comprehensive program integration of the EHDI data that follows the 
same protocols to assist in data sharing and data analysis.  For example, it would be 
useful to standardize the Infant Hearing Program protocol requirements nationally.   
1.2 Literature Review 
1.2.1 Early Detection 
The goal of international EHDI programs is to identify children with permanent 
auditory impairments in order to improve their communication outcomes in the areas of 
hearing, speech, and language.  It has now been well established that unidentified hearing 
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loss has a negative impact on communication development and that earlier identification 
of hearing loss leads to better results in communication, educational achievement, and 
social development in children (Robinshaw, 1995; Moeller, 2000; Yoshinago-Itano et al., 
2000).  
Early identification has been associated with better language development 
regardless of the method of communication (Yoshinago-Itano, 2003).  Specifically, mean 
language quotients were demonstrated to be better with early identification regardless of 
cognition levels (high or low), as well as vocabulary development, and speech ability.  
Moreover, early identification was shown to be especially important for those with 
additional disabilities, such as autism spectrum disorders (Yoshinago-Itano, 2003).  
Yoshinago-Itano, Coulter and Sedey (1998) studied 150 deaf and hard-of-hearing 
infants and children.  Children who were identified and put into intervention services by 
six months of age were found to have considerably improved language development 
compared to those who did not receive early intervention.  The researchers concluded that 
access to language within this early period is critical for developing language in the 
developmentally sensitive period (Yoshinago-Itano et al., 1998).  Additionally, children 
with hearing loss who were born in hospitals with newborn hearing screening were 2.6 
times more likely to have language development within the normal range than children 
with hearing loss born in hospitals without screening (Yoshinaga-Itano et al., 2000). 
A  study by Durieux-Smith, Fitzpatrick, and Whittingham (2008) compared 709 
children who were referred for hearing aid fitting and children were either diagnosed by 
neonatal screening or were diagnosed via medical referral.  Children who were screened 
were identified significantly earlier (mean 6.3 months) than referred children (mean 39.5 
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months).  Earlier identification enables families to obtain information and receive 
appropriate counseling and support while early intervention allows families to prevent 
certain language delays from occurring (Yoshinaga-Itano, 2003), supporting the notion 
that this early period is critical for language development.  Specifically, families may 
experience anxiety and frustration if the child is not attaining developmental milestones 
and they may attribute this falsely to “natural” development (Hyde, 2005).  The current 
detection tools in countries with mandated screening protocols are the most effective way 
to reliably detect the required range of hearing impairments in infants below six months 
of age.  These instruments include modern physiologic screening tests, in addition to 
modern, objective, diagnostic hearing assessment and surveillance in infants who do not 
pass screening or who are at risk for hearing loss (Hyde, 2005).  
1.2.2 Universal Newborn Hearing Screening 
Historically, prior to the implementation of newborn hearing screening programs, 
outcomes for children with severe to profound hearing loss were dismal, with adolescents 
graduating from high school with on average a grade three or four reading level and 
language levels of a nine to ten year old child with normal hearing (Traxler, 2000).  In 
1993, the National Institute of Health (NIH), as endorsed by the National Institute of 
Deafness and Other Communication Disorders (NIDCD) held a Consensus Development 
Conference.  This was a milestone in endorsing screening of all newborns prior to 
hospital discharge (NIH, 1993).  It has been suggested that the main problem with 
previously used targeted screening of infants with risk factors is that about 50% of infants 
with permanent childhood hearing impairment were not identified with any of the 
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targeted risk indicators.  Therefore, only around 50% of the total hearing-impaired cases 
were identified with this method  (Hyde, 2005).  
As standards continued to increase for early detection, the JCIH 2000 statement 
recommended universal newborn hearing screening (JCIH, 2000).  By 2005, 95% of 
infants in the United States had been screened, in contrast to 1993 where only 11 
hospitals in the United States were screening 90% of infants in their catchment areas 
(JCIH, 2007).  The JCIH principles include hearing screening by one month; screen fails 
should receive an audiological evaluation by three months and intervention services by 
six months.  The JCIH also recommended the use of risk factors as a supplement to 
universal newborn hearing physiological screening protocols.  The recommendation was 
that infants from birth to six months should have an evaluation for hearing risk factors 
and those at risk should receive audiological monitoring for delayed-onset, acquired, or 
progressive hearing loss.  Audiological evaluations for children at risk of hearing 
impairment should be conducted by 24 to 30 months of age, even if they pass initial 
screening but possess at least one hearing loss risk factor (JCIH, 2000; JCIH, 2007). 
Universal Newborn Hearing Screening is in practice in most developed countries 
and has dramatically improved outcomes for infants with hearing loss at birth.  In the 
United States, children have demonstrated language growth within the normal range of 
development at five years of age provided that they are enrolled in early intervention 
within the first year of life (Calderon et al., 1998; Moeller, 2000).  Additionally, UNHS 
programs have decreased the average age of hearing aid fitting in New South Wales from 
22 to 3.8 months, improving language and social outcomes where the prevalence was 
0.71-1.52/1000 births with congenital hearing loss (Hutt & Rhodes, 2008).  
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EHDI databases that include UNHS, diagnostic and habilitation outcomes are 
extremely valuable resources for data sharing for those involved in the management and 
research of childhood hearing impairments.  This source provides vital data for rates, 
trends, and features of children with permanent hearing loss (Hutt & Rhodes, 2008).  For 
example, in 2000, the JCIH showed that, of those who fail screening in the United States, 
only half have appropriate follow up services.  There are limitations to access and/or 
follow up, and it is difficult for state-funded EHDI services in the United States to 
integrate data and communicate this to the EHDI coordinators and the many different 
stakeholders involved.  For a successful EHDI program, pediatricians, family physicians, 
and other health care professionals, who are funded through a myriad of different 
sources, must work in partnership with parents and other professionals such as 
audiologists, physicians, program managers, family support workers, and educators.  
And, importantly, there must be collaboration among different institutions that assume 
responsibility for different aspects of the patient’s care (screening, evaluation, 
intervention) (JCIH, 2007).   
A recent study by Moeller, Carr, Seaver, and Stredler-Brown (2013) examined the 
best practices in EHDI programs, specifically family-centered early intervention for 
children.  The goal was to promote widespread, evidence-based recommendations for 
family-centered early interventions.  The consensus advocated early, timely, and 
equitable access to services.  The main focus was on family involvement and 
partnerships, along with best practice principles for families to make appropriate 
decisions and means of communication with their child.  This included the use of 
assistive technologies and supporting means of communication (Moeller et al., 2013).     
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1.2.3 Postnatal Hearing Impairment 
It is still the case that not all permanent hearing impairments are identifiable at 
birth (Fortnum, 2003).  The goal and mandate set out by groups such as the NIH and the 
JCIH are to detect all types of hearing loss, even mild, unilateral, or neural hearing 
impairments that can have significant developmental effects (JCIH, 2007).  Little is 
understood about the numbers and features of infants who develop significant hearing 
loss after passing initial newborn hearing screening (Hutt & Rhodes, 2008).   
A current challenge in the field of audiology is identifying those children who 
develop hearing problems after passing the initial newborn screening.  Postnatal hearing 
loss includes acquired, late onset, or progressive hearing loss and these categories are 
hard to distinguish due to the ambiguous causes and time of onset (Hutt & Rhodes, 
2008).  Little is known about prevalence or how to predict these cases so that more 
research in this area is required.  Fortnum (2003) reviewed different studies and the 
incidence of late onset, acquired, or progressive hearing loss ranged from 7.5-25.2% of 
all hearing-impaired children.  Reasons for such a range in prevalence rates could include 
differences in demographics, or methodology, such as different definitions for each 
hearing loss group (Fortnum, 2003).    
Weichbold, Nekahm-Heis, and Welzl-Mueller (2006) conducted a large Austrian 
retrospective clinical analysis with 105 cases of permanent childhood hearing loss.  All of 
the cases had received a valid newborn hearing screen.  Results showed that 23 of these 
children had hearing within the normal range at birth.  After adjusting for under-
ascertainment, the researchers found that around 25% of significant permanent childhood 
hearing impairments diagnosed by nine years of age were postnatal and undetected by 
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universal hearing screening (Weichbold et al., 2006).  This has implications for future 
research and implies that UNHS programs may not be sufficient to capture all permanent 
childhood hearing impairments, where postnatal surveillance programs and improved 
surveillance protocols might. 
An important consideration is that not all prenatal aetiologies lead to an 
impairment that is detectable at birth by screening (Hutt & Rhodes, 2008). Therefore, 
postnatal hearing loss could be informed by retrospective analysis of any confirmed cases 
by evaluating screening databases to determine if there is a need for improved screening 
or diagnostic procedures (Hutt & Rhodes, 2008).  Of vital importance to evaluation of 
early hearing detection and intervention programs (EHDI) is the prevalence of children 
who not only have congenital hearing loss, but those who develop an impairment 
identified after newborn screening (Fortnum, 2003).  The data from large databases of 
EHDI programs could be useful for establishing practice and policy for children with 
different hearing loss outcomes, including progressive and emergent postnatal hearing 
loss.   
1.2.4 Risk Factors and Surveillance 
The JCIH lists 11 risk factors that overlap among risk factors for congenital and 
acquired, late onset, and progressive hearing loss.  JCIH (2007) risk factors include the 
following: (a) caregiver concern; (b) family history of permanent childhood hearing 
impairment; (c) neonatal intensive care, based on duration and procedures delivered; (d) 
in utero infections; (e) craniofacial anomalies; (f) physical findings that are associated 
with a syndrome known to cause permanent childhood hearing impairment; (g) 
syndromes associated with permanent childhood hearing impairment; (h) 
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neurodegenerative disorders; (i) culture-positive postnatal infections associated with 
sensorineural hearing loss; and (j) head trauma. 
The JCIH recommends audiological surveillance of all infants with risk factors in 
localities where there is no UNHS available by following them for the emergence of post-
natal hearing loss, and also for those with risk factors but who pass screening in those 
areas with comprehensive EHDI programs, (JCIH, 2007).  Although the JCIH (2000) 
guidelines advocated audiological monitoring for all infants with risk indicators at six-
month intervals, there have been concerns about the feasibility and costs of such an 
endeavor (JCIH, 2000).   
1.3 Challenges and Future Directions 
There are only a few EHDI programs that currently have the capacity to report the 
number of infants screened, assessed, and registered in intervention programs, and the 
JCIH promotes data pooling and assessment of these programs for future policy and 
practice (JCIH, 2007).  There are many challenges and obstacles to assessing and 
managing EHDI programs such as the following: tracking outcomes of children after 
failing screening; a lack of specially trained professionals; need for the integration of data 
through coordinated management and tracking systems; a lack of timely referrals and 
surveillance programs; and insufficient funding (JCIH, 2007).   
There is a need for evidence-based research to determine the design and cost 
effectiveness of surveillance programs.  In addition, EHDI programs have the difficulty 
of deciding on protocols regarding the risk factor inclusion criteria used to target 
surveillance.  Risk factors, without being too broad or too narrow, should have high 
predictive power in terms of identifying hearing loss (Hutt & Rhodes, 2008).  Moreover, 
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there is a lack of parental disclosure of certain risk factors and under-utilization of 
surveillance program follow up services.  Finally, the cost of audiological assessment is a 
policy factor in determining the feasibility of monitoring services.   
EHDI data from comprehensive programs can be used to investigate program 
issues and provide evidence for economic and social justification for surveillance 
programs (Hutt & Rhodes, 2008).  For example, Weichbold et al. (2006) recommend 
preschool surveillance, as a secondary screen, a program they consider both 
advantageous and feasible.  Ultimately, the goal of EHDI programs is to find a timely 
way to identify all children with hearing loss and to assess the program components that 
are currently in place. 
A comparison of these hearing outcomes across populations that have different 
risk levels is needed to improve screening and assessment, for example, infants who pass 
or fail newborn screening, and those with and without protocol defined risk factors 
[Appendix C].  The JCIH has identified the critical need for longitudinal studies and 
population-based studies to determine the prevalence and natural history of these hard-to-
detect hearing disorders and evaluation of risk factors contributing to hearing loss (JCIH, 
2007).  Establishing this foundation in evidence-based research will help in the design of 
appropriate prevention and intervention strategies.   
1.4 Review of the Ontario Infant Hearing Program 
(IHP) 
Neonates born in Ontario receive services through the Ontario Infant Hearing 
Program (IHP), a comprehensive screening, diagnostic, and habilitation program.  
Throughout this thesis, the program will be referred to as the IHP, although different IHP 
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programs outside Ontario may have different protocols.  Children from birth to six years 
of age, who are at-risk for hearing impairment, are evaluated by the Ontario IHP and 
receive audiological assessments and related services.  All audiological services are 
delivered by IHP trained pediatric audiologists using standardized protocols and clinical 
equipment (Hyde, 2008).  Hearing assessment objectives are to obtain IHP protocol 
approved estimates of ear and frequency-specific hearing thresholds, in addition to 
diagnosing the type of any hearing impairment, if present.    
The IHP is one of the few programs worldwide that has standardized (risk factor, 
questionnaire, behavioural, and physiological) screening and diagnostic protocols within 
a comprehensive surveillance, assessment, and habilitation program for children at 
increased risk for hearing loss.  The H.A. Leeper Speech and Hearing Clinic IHP, which 
was implemented in 2002, provides comprehensive physiological and behavioural 
assessment and intervention programs for children “at-risk” for developing auditory 
impairments.  To note, once hearing loss is diagnosed and an individualized plan is 
defined, families often transfer to another IHP site for follow-up habilitation and other 
counseling services more conveniently located in their region.  
Children are considered “at risk” and referrals to the IHP are accepted: (a) if a 
child fails their initial newborn hearing screening; (b) if they are identified with a 
potential communication disorder and referred by an outside party (parent, physician, 
teacher); (c) if they are either reactived after passing their initial screening or if they are 
transferred within the IHP region; or (d) if a child harbours specific hearing-related risk 
factors (at least one).  Also, the IHP provides comprehensive long-term surveillance for 
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every child considered to have at least one IHP defined risk factor, but who passed the 
initial universal screening assessment [Appendix E].   
The IHP audiological assessment protocol includes age appropriate acoustic 
immitance with conventional and 1 kHz frequency tympanometry, distortion product 
otoacoustic emissions (DPOAE), air and bone conduction auditory brainstem response 
(ABR) using click and frequency-specific tone pips (0.5-4 kHz), visual reinforcement 
audiometry (VRA), conditioned play audiometry (CPA), and conventional audiometry, 
while employing the appropriate methodology dictated by the age of the child (Hyde, 
2008) by IHP trained audiologists with pediatric expertise [Appendix A].  The audiology 
assessment follows prescribed equipment and procedures based on the current version of 
the IHP protocol.  These IHP protocols are designed to ensure the validity and reliability 
of thresholds obtained via physiological and behavioural techniques. 
In summary, children from birth to six years of age, who are at-risk for hearing 
loss according to any of the above criteria, are flagged upon screening through the IHP 
and followed with assessments and services. As stated earlier, evidence-based research is 
needed to design appropriate prevention and intervention strategies.  This thesis is 
intended to contribute further to this identified need. 
1.5 Rationale and Implications of This Thesis            
      Given the insufficient amount of current evidence, this present retrospective 
analysis of the comprehensive data set from the Ontario Infant Hearing Program 
screening and surveillance program at Western University provides unique
 
data for 
children at-risk for hearing loss.  The H.A. Leeper Speech and Hearing Clinic at Western 
University has extensive experience with infant hearing assessment and surveillance 
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programs and has a large database of patients.  Analysis of these data as a population-
based study has the potential to advance knowledge in this important area and to 
potentially provide a significant contribution to EHDI programs and policies both 
nationally and internationally.       
The main objective of this present retrospective thesis is to evaluate audiological 
assessment outcomes for all children and infants receiving assessment and surveillance 
services through one Ontario IHP clinic site located at Western University within the 
H.A. Leeper Speech and Hearing Clinic.   
This data set is of importance due to the large number of children and the unique 
characteristics of this sample.  Few studies have evaluated a clinic sample in which the 
intake for the clinical population is exclusive to an early hearing detection and 
intervention program, in this case, the Ontario IHP.  Unlike the previous studies of this 
type, which focus on the outcomes of universal newborn screening (Robinshaw, 1995; 
Moeller, 2000; Yoshinago-Itano et al., 2000) or a surveillance program for high risk cases 
(Beswick, Driscoll, Kei, & Glennon, 2012 ), this thesis includes pediatric cases 
originating from all types of referral sources within this infant hearing program, and 
compares the outcomes across these different referral groups.                                 
1.6 Hypotheses & Research Questions 
This study is a descriptive analysis of an Infant Hearing Clinic sample in Ontario, 
and compares the population characteristics and hearing outcomes across the different 
intake referral source groups permitted under the Ontario IHP and governed by their 
protocols.  The following five referral group acronyms are used: Newborn hearing screen 
15 
 
fail (NHSF), IHP surveillance group (SURV), external referral (EXT), IHP reactivation 
(REACT), and IHP transfers (TRANS).   
Research Question 1: 
What are the hearing outcomes of infants referred to the Ontario IHP clinic site 
located at Western University within the H.A. Leeper Speech and Hearing Clinic, a clinic 
with an intake population exclusive to a comprehensive infant hearing detection and 
intervention program. Do the hearing outcomes differ, depending on the reason for 
referral?  
Hypothesis 1: 
It is hypothesized that the IHP hearing assessment outcomes, specifically the 
presence/absence of hearing impairment, will vary as a function of the IHP Referral 
Source Group (i.e., reason for referral/assessment). 
Research Question 2: 
What is the risk factor status, specifically the presence/absence of a hearing risk 
factor(s), and nature of hearing loss (type, severity, symmetry) in the different Referral 
Source groups for the University of Western Ontario IHP clinic? 
Hypothesis 2 
It is hypothesized that the nature of the hearing loss and risk factor status will vary 
depending on the reason for referral to the Western University Ontario IHP clinic.  
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1.7 Thesis Format 
Chapter 1 provides a brief introduction and a review of the literature and 
summarizes the rationale and research questions addressed in this thesis. Chapter 2 
provides a detailed description of the methods used to address the research aims and 
objectives in Chapter 1. Chapter 3 presents the results, and Chapter 4 highlights the 
results and discusses their relevance in the context of the current literature and for 
potential future policy decisions. 
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Chapter 2  
2 Materials and Methods 
2.1 Research Design 
This thesis is a descriptive retrospective analysis of data from a cohort of children 
enrolled in the Ontario IHP and receiving services at the H.A. Leeper Speech and 
Hearing Clinic site at Western University.  In this thesis, the H.A. Leeper Speech and 
Hearing Clinic will be referred to as the H.A. Leeper Clinic. The study population 
includes patients referred during the time frame between IHP implementation in February 
2002 through August 2011.  This thesis assesses the site’s population as a descriptive, 
population-based study to determine the different outcome measures for certain infants, 
who are at-risk for developing hearing impairment based on specified at-risk groups.  
This thesis was approved by the Research Ethics Board December 22, 2011 under review 
#: 17385E.   
2.2 Study Population 
All subjects were drawn from a patient cohort at risk for having or developing 
hearing loss, as defined by the IHP, and who were subsequently evaluated at the H.A. 
Leeper Clinic IHP site. The IHP at the H.A. Leeper Clinic is part of the IHP 
Southwestern Ontario Regional Centre [Appendix F].  
The IHP provides comprehensive physiological and behavioural assessments and 
intervention programs for children “at-risk” for hearing loss as mandated by the Ontario 
IHP protocol (Hyde, 2008).  Subjects were drawn from the group receiving the following 
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services: surveillance screening and full diagnostic assessment.  Assessment types and 
timing of initial assessment are described in detail based on the protocol in Appendix E.   
This thesis looked at a subset of children receiving IHP services at the H.A. 
Leeper Clinic, according to the following inclusion criteria: (a) children completing at 
least one IHP evaluation because they failed their newborn hearing screening (with or 
without a risk factor); (b) children completing at least one IHP evaluation because they 
have an IHP designated risk indicator, but passed their newborn hearing screening; (c) 
children completing at least one IHP evaluation because of a community referral 
(parent/guardian, teacher, physician concern about communication development) and (d) 
transfers into the southwestern IHP region.   
Candidacy for IHP Audiological Services begins at birth and now includes 
children up to the age of six years, or entry into Grade 1 (Hyde, 2008).  Children initially 
enrolled for services through the IHP, but who did not complete at least one diagnostic 
assessment or surveillance screening through the IHP were excluded from this thesis.  
Hearing loss can be defined as unilateral or bilateral permanent hearing loss. The 
IHP definition for permanent childhood hearing loss is: one or more thresholds equal to 
30 dB HL or greater (0.5 to 4 kHz), with each ear classified as a conductive, mixed, 
sensorineural, or auditory neuropathy spectrum disorder type of hearing deficit (Hyde, 
2008).  Children who were referred to the IHP and who were later either identified with 
permanent childhood hearing impairment, or normal hearing, were included in this thesis 
according to the IHP criteria at the H.A. Leeper Clinic site. 
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2.3 Data Collection 
2.3.1 Electronic IHP Database Review 
The H.A. Leeper Clinic IHP electronic database was reviewed for eligible 
participants. This is a comprehensive site-specific database maintained by the IHP 
coordinator at Western University. Review of the IHP electronic database in the H.A. 
Leeper Clinic was completed retrospectively.   
2.3.1.1 Electronic Database: Data Extraction and Analyses 
Data extracted from the electronic database includes, gender, date of birth, 
hearing loss status, referral source, and presence of at least one risk factor.  The “hearing 
status” field in the database identified subjects as hearing-impaired or normal hearing, 
based on IHP criteria. The definition of permanent childhood hearing impairment 
according to the IHP criteria includes (1) any hearing threshold equivalent to 30 dB HL 
or greater at any frequency in the range 0.5-4 kHz, in either one or both ears (2) any of 
the following permanent childhood hearing impairment: conductive impairment 
associated with structural anomalies of the ear (but not inclusive of non-structural middle 
ear conditions), mixed, sensorineural, auditory neuropathy spectrum disorder, and 
retrocochlear disorders, involving the auditory brainstem (3) ages birth-six years (Hyde, 
2008, [Appendix B]). 
2.3.1.2 Referral Source Groups  
Upon exporting data from the IHP database, referral sources were available for 
nearly all subjects.  Referral source describes the route through which children are 
referred to the H.A. Leeper Clinic IHP site.  These data are particularly useful for 
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examining aspects of the newborn screening and surveillance program, which are 
discussed later in detail.  IHP assessment is available to the following children in a timely 
matter as mandated by the IHP:  neonates and infants who fail IHP UNHS or who fail 
IHP high risk surveillance; children up to six years with permanent childhood hearing 
impairment proven by previous IHP assessment or audiometry outside of the IHP; and 
children up to six years who acquire IHP high risk status extrinsically or through post-
natal IHP risk indicator identification (Hyde, 2008).  The IHP electronic database 
documents information about the referral (route and reasons for referral, assessment type) 
for each child seen for audiological services.    
For this thesis, subjects were assigned to five main groups.  These five Referral 
Source groups are defined and will be referred to as: 
1. Newborn Hearing Screen Fail (NHSF); 
2. IHP Surveillance (SURV);   
3. External Referral (EXT);   
4. IHP Transfer IN (TRANS); and 
5. IHP Reactivation (REACT) 
NHSF include those babies referred to the IHP with at least one ear failing newborn 
screening. For the purpose of clarity in this thesis for those readers not in the field of 
audiology, newborn hearing screen “fail” will be called “fail”, instead of  the accepted 
clinical terminology “refer”, since this terminology may be more familiar to the general 
healthcare policy audience,.  It is clinically more advised to use the term “refer” versus 
“fail” due to the negative connotations that may be perceived with the latter (Hyde, 
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2005), but may cause confusion in this thesis because we are studying a variety of 
different referral routs into the IHP program at the Western University site.   
The following summary describes these referral routes and groups included in this 
thesis. SURV children were referred to the IHP even though they passed newborn 
screening in both ears, because they had at least one hearing risk factor as per IHP 
protocol [Appendix C].  EXT includes those children who received a referral from a 
physician, or from a concerned parent, teacher, or other external source.  For some of 
these cases, hearing screening results may be unknown if the child was missed or did not 
receive newborn screening (born prior to IHP implementation in 2002).  To note, health 
care referrals were previously accepted into the IHP, whereas all referrals now must be 
referred from a physician.  Cases in the REACT group involve children who originally 
passed their newborn screening but concerns were raised later and were, therefore, 
reactivated in the IHP.  Finally, children can be transferred into the IHP, either within the 
IHP region or by another IHP region (Hyde, 2008), and these children were assigned to 
the TRANS group.  Once these categories were assigned, the subjects were then sorted 
according to their hearing status into normal hearing and hearing-impaired groups.  
Figure 1 presents an overview of the IHP structure and illustrates the Referral Source 
groups evaluated in this thesis.   
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Figure 1.  An Overview of the IHP Structure and the Referral Categories to the IHP from 
Newborn Screening. 
Note.  In this diagram, “refer” means that the child would “fail” the screening test and be referred for a 
complete IHP Audiologic Assessment. 
2.3.2 Chart Review 
Those identified from the IHP electronic database with a hearing impairment were 
included in the chart review (n=219).  Clinical charts for these subjects were retrieved 
and data extracted. Following the identification of permanent childhood hearing 
impairment through the IHP, a child is reassessed every three months during the first 
year, and at least every six months thereafter, thus providing serial audiograms and/or 
ABR threshold estimates for the majority of participants.   
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2.3.2.1 Clinical Chart Review: Data Extraction 
 Data extraction from the clinic charts included the results for newborn hearing 
screening and high-risk surveillance, risk factor status, community screening outcomes, 
and audiological assessment measurements.  The audiologic measurement data included:  
age in months at time of audiological assessment, hearing test type (Auditory Brainstem 
Response [ABR], Visual Reinforcement Audiometry [VRA], Conditioned Play 
Audiometry [CPA], other), hearing loss type (sensorineural, conductive, mixed, auditory 
neuropathy, none, or unknown) test ear (right or left), pure tone  air and bone conduction 
threshold data (0.5, 1, 2 and 4kHz) [Appendix A].  Tympanometry data were included 
and immitance data consisted of: date of test, frequency of probe (226 Hz, 1 KHz, other), 
machine model, middle ear pressure (daPa), peak static admittance (ml), and ear canal 
volume (ml).   
  Risk factor data were collected for all subjects in the hearing-impaired group. IHP 
risk factors are listed in Appendix C (Hyde, 2008).  Risk factors were documented in the 
clinical chart as follows: “Presence of a risk factor?”, where the clinician must indicate 
“yes”, or  “no”.  Therefore, it was possible to extract and record whether each subject had 
at least one IHP defined risk factor present, and if it was indicated “no”, the child was 
considered to have no known risk factor(s).  
2.4 Data Analyses 
The nature of the hearing loss was studied for each subject defined as hearing-
impaired.  Only thresholds considered valid and reliable were included in the data 
analyses.  Thresholds were considered valid based on the parameters of the IHP protocol.  
24 
 
Therefore, if there were any questions of reliability, these values were not included based 
on rules of immitance, ABR, VRA, and CPA guidelines (Hyde, 2008).  Threshold values 
with no response at the limit of the audiometer were entered as the threshold 5 dB greater 
than the limit of the audiometer so that it could be distinguished between “not tested” and 
“no response” at the upper limit, thus enabling PTA calculations [Appendix A].   
Furthermore, hearing assessment results were excluded from data analyses for any 
visit where bone conduction thresholds and/or immitance testing indicated temporary 
middle ear abnormalities, because middle ear status can influence behavioral and 
physiological outcomes, leading to misinterpretation of the nature and stability of the 
hearing loss.  Threshold immitance values were considered abnormal if they did not meet 
the IHP criteria for acceptable peak static admittance for the specified age and/or if 
tympanometric peak pressure was greater or equal to +/-200 da PA. [Appendix D].  It is 
not unusual for some pure tone thresholds not to be measured on any given assessment, 
particularly for young children.  Missing thresholds were identified as such.  For data 
analyses, the closest behavioral test date with the most complete threshold information 
was then used.  Subject age was calculated for each visit. Finally, subjects who only 
received ABR testing were classified as “ABR audiogram only”. 
2.4.1 Degree (Severity) of Hearing Loss 
Pure tone hearing thresholds were analyzed for each hearing test date, with many 
subjects having multiple hearing tests.  For each test date, air conduction pure tone 
thresholds were analyzed for each ear separately. Severity of hearing loss was, therefore, 
classified for each ear separately and only ear-specific results obtained with earphones 
were used. 
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The mean threshold for each ear was calculated using both the three and the four 
frequency pure tone averages: PTA3 (0.5, 1, and 2 kHz) and PTA4 (0.5, 1, 2, and 4 kHz). 
The results of the pure tone average calculations (PTA3 or PTA4) were categorized as: 
normal (-10 to 15 dB hearing level [dBHL]), slight (16 to 25 dBHL), moderate (26 to 40 
dBHL), moderately severe (56 to 70 dBHL), severe (71 to 90 dBHL), or profound (>90 
dBHL) (Clark, 1981).  These categories follow Clark’s criteria, who used PTA3 only, a 
definition of pediatric hearing severity recommended by the American Speech-Language-
Hearing Association (ASHA) (Clark, 1981).     
 For the purpose of this thesis, both PTA3 and PTA4, have been included for 
comparison purposes.  Table 2 below demonstrates the commonly accepted 
classifications of hearing impairment. For defining an individual subject’s hearing loss 
severity, the better ear (BE) threshold was used if hearing loss was bilateral, whereas the 
worse ear (WE) threshold was used for unilateral hearing loss cases (Clark, 1981).  The 
pure tone average thresholds and hearing loss severity were based on the most recent 
behavioral audiogram. 
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Table 1 
Classification of Hearing Impairment 
Hearing Level (dBHL)  Classification 
-10 to 15  Normal hearing 
16 to 25  Slight hearing loss 
26 to 40  Mild hearing loss 
41 to 55  Moderate hearing loss 
56 to 70  Moderately severe hearing loss 
71 to 90  Severe hearing loss 
> 90  Profound hearing loss 
 
2.4.2 Hearing Loss Type 
According to the IHP protocol, the audiologist indicates the type of hearing loss 
for each hearing test, and includes the identification of permanent conductive hearing 
components in conductive and mixed losses, as well as auditory neuropathy spectrum 
disorder in this classification.  Specifically, hearing loss type was classified as follows: 
conductive, sensorineural, mixed, auditory neuropathy, or unknown.  As with hearing 
loss severity, this analysis is determined for each ear, and is based on the most recent 
behavioral test for which this data (hearing loss type) was available. Cases in which 
hearing loss type was defined with only ABR testing data available have been grouped as 
“ABR audiogram only”.  Cases that were unclear in regards to hearing loss type were 
labeled as “unknown”, for the following reasons: no reliable threshold data were 
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available, incomplete clinical data forms, hearing loss type was queried and/or the test 
type was contradictory for different test dates.   
2.4.3 Symmetry of Hearing Loss 
Symmetrical hearing means that hearing thresholds are similar in each ear, while 
asymmetrical refers to a between ear difference in these thresholds.  In this thesis, the 
symmetry of pure tone hearing thresholds was analyzed, and was based on the most 
recent behavioral audiometric test.  Hearing loss was defined as unilateral when the 
hearing thresholds in one ear were within normal limits, defined as a mean three 
frequency pure tone average, PTA3
0.5-2kHz
, of 20 dB HL or less, with the other (worse) ear 
below this limit (Pittman & Stelmachowicz, 2003).  Bilateral asymmetric hearing loss 
was present when both ears were below this normal range, and the ears differed by 15 dB 
or more (>20 dB) at one or more frequencies (thresholds for all 4 frequencies and both 
PTAs were analyzed) (Pittman & Stelmachowicz, 2003).  
When a subject had only ABR audiometric evaluations, this is noted and these 
were excluded.  For the purposes of this thesis, the evaluation of symmetry was based on 
the most frequently measured pure tone thresholds (IHP protocol dictates measurement 
and reporting of these frequencies) in our population: 0.5, 1, 2, and 4 kHz.  Cases with 
only unilateral testing and ABR thresholds only were excluded from the analysis. 
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Chapter 3  
3 Results 
3.1 Data Retrieved from the Electronic Database 
3.1.1 Overview 
The subjects of this thesis consist of 2,638 children who were enrolled at the H.A. 
Leeper Clinic IHP site between 2002 and August 2011.  These subjects were referred to 
the IHP through several different routes, and are classified according to the outcome of 
their hearing assessment or surveillance testing as either normal hearing, or hearing 
impaired.  Of this total, 2,390 children were determined to have normal hearing.  Gender 
was recorded for the normal hearing population, with 31.9% (n=763) males, 25.4% 
(n=608) females, and 42.6%, (n=1,019) of unknown gender.  Unknown cases were those 
for which gender data were missing for the “gender” field in the electronic database.  
Conversely, 248 cases were identified with hearing loss.  More than half of the children 
identified by the IHP database with hearing loss (n=248) were male (62.9%; n=156) and 
37.1% (n=92) were female. Table 2 depicts the distribution of gender for both hearing-
impaired and normal hearing cases.   
 
 
 
 
29 
 
Table 2 
Study Population Based on the Electronic Database 
Note.  Percentage totals may not add to 100 due to rounding. 
3.1.2 Referral Routes 
Based on data retrieved from the electronic database, 2,638 children were referred 
to the IHP through a variety of different routes and subsequently enrolled in the IHP at 
the H.A. Leeper Clinic during the study period 2002-2011.  The study sample was broken 
down into two groups based on the referral route and also on the outcome of their 
audiological assessment: Normal Hearing (n=2,390) and Hearing Impaired (n=248).  The 
definition of hearing outcome was based on the IHP protocol definition of normal hearing 
[Appendix B].   
There were five different referral routes to the IHP, and the sample was divided 
into five groups: Newborn Hearing Screen Fail (NHSF), IHP Surveillance (SURV), IHP 
Reactivation (REACT), IHP Transfer In (TRANS), and External Referrals (EXT).  Table 
3 is a summary of the study sample, showing both the referral route into the IHP, and the 
hearing outcome for each Referral group.  
Study Population  Hearing-impaired cases Normal hearing 
cases 
Total 
Total 248  2,390 2,638 
Males  156 (62.9%) 763 (31.9%) 919 (34.8%)  
Females 92 (37.1%) 608 (25.4%) 700 (26.5%)  
Unknown 0 (0.0%) 1,019 (42.6%) 1,019 (38.6%) 
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Table 3 
An Overview of the Electronic Database by Referral Group 
Referral Source 
groups 
Hearing-impaired 
group total 
 
Normal hearing 
group 
 
Total 
 
NHSF 143  550  693  
SURV 23 1,536  1,559  
REACT 31  101  132  
TRANS 22  56  78  
EXT 28  132  160  
Missing Data* 1  15  16  
Grand Total 248 2,390 2,638 
*Note.  Data not entered in the electronic database.  Note that percentages may not add up to 100% due to 
rounding. 
The majority of the sample was referred to the IHP for audiological surveillance, 
with 59.1% (n=1,559/2,638) of the sample in the SURV group.  The NHSF group, 
assessed because they failed their newborn hearing screening, has the second largest 
number of children referred, with 26.3% (n=693/2,638).  Those who entered the IHP by 
other routes, the EXT, REACT, and TRANS groups constitute the remainder of the study 
sample: EXT have 6.1% of the total (n=160/2,638), REACT at 5.0% (n=132/2,638), and 
TRANS with 3.0% (n=78/2,638).  Data for referral route and audiological assessment 
were essentially complete; only 0.6% of the study sample had missing data in the 
“Referral group” field in the electronic database.   
Figure 2 depicts the number of cases identified with hearing loss by the total 
number referred for each group. The hearing outcome for SURV, the largest Referral 
group, enrolled in the IHP for audiological surveillance, revealed a low detection rate, 
with only 1.5% of cases identified with permanent childhood hearing loss              
(SURV: n=23/1,559).  One of the main objectives of this research is to examine the 
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effectiveness of the IHP Surveillance Program.  The data in Table 3, particularly the 23 
SURV cases as a fraction of the total (1,559), if extrapolated to a provincial total, could 
indicate the number of potential beneficiaries of surveillance.  For the NHSF Referral 
group that failed neonatal hearing screening, the audiological testing outcome more 
frequently revealed a hearing impairment, with 20.6% (n=143/693) identified with a 
permanent childhood hearing impairment.  For the EXT and REACT Referral groups, the 
detection rate for hearing loss was also high at 17.5% (28/160) and 23.5% (31/132) 
respectively, suggesting that the policy of accepting referral from the community is an 
appropriate means of detecting cases missed by neonatal screening, or those with 
emerging postnatal hearing losses. 
In summary, these data illustrate that the majority of children referred to the IHP 
at the H.A. Leeper Clinic site had a normal hearing outcome on audiological assessment 
(Figure 2). Although the SURV group received the highest number of referrals, the vast 
majority in this Referral group, were normal hearing, despite having at least one risk 
factor; 98.5% were discharged from audiological surveillance with a normal hearing 
outcome.  For the second largest Referral group, NHSF, 79.4% (n=550/693) did not have 
hearing loss, based on the outcome of their complete audiological assessment, despite 
failing the neonatal hearing screening.   
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Figure 2.  An Overview of Referral Source Category Data. 
3.1.3 Risk Factor Data 
Hearing risk factor presence/absence data were extracted using this data field in 
the electronic database and results were analyzed. For those subjects with data available 
in the electronic database, 46.2% of those children with normal hearing were identified 
with a risk factor (n=1,103/2,390), whereas only 5.2% did not have a known risk factor 
(n=124/2,390).  In the hearing-impaired group, 66.1% were identified with at least one 
risk factor (n=164/248), and 27.8% (69/248) did not have a known risk factor.   
However, data from the risk factor field of the electronic database were missing 
for a significant proportion of the sample.  The normal hearing group was missing 48.7% 
(n= 1,163/2,390) of the risk factor data and the hearing-impaired group was missing less 
with 6.0% (n =15/248).  In many cases, this data field may have been empty because the 
hearing risk factor status was inferred from other data fields. For the SURV group 
(n=599), it is required that, based on the IHP protocol, all of these cases have at least one 
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risk factor present.  Furthermore, the 24 cases that were defined as not having a risk 
factor in the electronic database are presumed to be data entry errors. 
3.2 Data Retrieved from the Chart Review 
3.2.1 Overview 
Clinical chart review was performed on all cases classified as hearing-impaired in 
the electronic database (n=248).  These charts were reviewed for data pertaining to 
hearing loss features, including threshold data, and thus provided confirmation of the IHP 
designation of permanent childhood hearing impairment.  Twenty-nine charts were not 
available, were considered missing data, and were excluded from further analyses, 
leaving a total sample of 219 hearing-impaired cases for further detailed analyses.   
3.2.2 Referral Routes 
Table 4 data describes the referral route for the cohort with hearing impairment, 
based on chart review.  The NHSF group comprised the majority of the study sample for 
the hearing-impaired group as hypothesized with 58.4% (n=128).  These children failed 
screening and were subsequently referred to the IHP, and then identified with some type 
of hearing impairment.   
The remaining cases were equally divided among the last three Referral route 
groups: EXT comprised 12.3% (n=27) of this group, while REACT and TRANS 
encompassed 11.4% (n=25) and 8.7% (n=19), respectively.  Finally, the SURV group, an 
important group to examine, constituted 9.1% of those identified in the hearing-impaired 
group based on charts available for review (n=20).  
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Table 4 
An Overview of the Referral Source Category Data 
Referral Source groups Hearing impaired-group analyzed 
 
Percentage by Referral 
group 
(%) 
NHSF 128  58.4 
SURV 20  9.1 
REACT 25  11.4 
TRANS 19  8.4 
EXT 27  12.3 
Data not available* 0  0 
Grand Total 219 100 
*Note. Data not available as the data entry field was blank in the electronic database. 
The NHSF group contained the most cases of hearing impairment (n=128) and is, 
therefore, the group that appears to benefit most from newborn screening programs, as 
documented in the literature and by the JCIH (JCIH, 2007).  EXT, REACT and TRANS 
children also contributed to the total hearing-impaired sample with close to 32.4% of 
hearing-impaired cases.  
3.2.3 Risk Factor Data 
Infants who pass hearing screening and have no hearing risk factors according to 
IHP protocols are not enrolled in the IHP.  However, infants who pass their newborn 
hearing screening but have one of the IHP risk factors are considered “at-risk” and are 
entered into the audiological Surveillance Program. By nature of their group status, all 
those in SURV have at least one risk factor.  Documentation of risk factor information 
was performed using the clinical charts to extract new data, and cross-check information 
derived from the electronic database.    
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It is important to note that the electronic database and the clinic IHP data forms 
only capture the presence or absence of a risk factor.  Although risk factors were often 
listed in the chart, the IHP only requires the presence of at least one risk factor, limiting 
us from examining a comprehensive list of risk factors.  Overall, 69.9% (153/219) of the 
hearing- impaired group had at least one risk factor, whereas 28.3% (62/219) did not have 
a risk factor.  For a small number, the risk factor status was unknown (1.8%; n=4/219).  
These were cases where the data were not recorded in the chart (n=3) or the actual risk 
data were unknown because the child was adopted (n=1).   
Table 5 shows risk factor data by Referral group for the hearing-impaired group 
from chart review (n=219).  All hearing-impaired children in the SURV group had at 
least one risk factor identified, as expected, since this is the criterion for enrollment in the 
IHP Surveillance Program. For those hearing-impaired children in the NHSF group, 
referred because they failed their newborn hearing screening, the majority (74.2%; 
n=95/128) also harboured at least one IHP hearing risk factor.  The EXT group had just 
over half (55.6%; n=15/27) identified with at least one risk factor while the TRANS 
hearing-impaired cohort had (57.9%; n=11/19).  Lastly, the REACT group had 48% 
(n=12/25) cases with at least one risk factor. 
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Table 5 
Referral Source Data and Risk Factor Presence in the Hearing-Impaired Group Referred 
to the IHP (n=219) 
 
 
Referral groups (n=219) 
Risk factor 
 
Risk factor 
present  
No known risk 
factor 
 
Risk factor 
unknown   
 
NHSF 
n=128 (58.4%) 
95 (74.2%) 33 (25.8%) 0 (0.0%) 
SURV 
n=20 (9.1%) 
20 (100%) 0 (0.0%) 0 (0.0%) 
REACT 
n=25 (11.4%) 
12 (48%) 12 (48%) 1 (4.0%) 
TRANS 
n=19 (8.7%) 
11 (57.9%) 6 (31.6%) 2 (10.5%) 
EXT 
n=27(12.3%) 
15 (55.6%) 11 (40.7%) 1 (3.7%) 
TOTAL 
N=219 
153 (69.9%) 62 (28.3%) 4 (1.8%) 
Note. Total n=248.  n=29 charts were not available, therefore, n=219 cases were 
analyzed. 
3.2.4 Hearing Loss Type 
There are three basic types of hearing loss described in the literature: 
sensorineural, conductive, and mixed.  Auditory neuropathy is another type of hearing 
loss targeted by the IHP, and is categorized as such.  For those cases where hearing loss 
type is not confirmed by the end of this thesis, they are labelled as “unknown”.  Unknown 
cases were examined in detail, as they may be unknown for different reasons.    
Tables 6 and 7 and Figures 3-6 summarize bilateral and unilateral hearing loss 
with a breakdown of hearing loss type in each category, and further subdivided by 
Referral group.  Table 6 (Figures 3 and 4) provides data for all cases with a behavioural 
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audiogram; the most recent behavioral audiogram with available hearing loss type data 
was used.  Table 7 (Figures 5 and 6) provides data for those with ABR results only.   
Table 6 
Hearing Loss Type by Referral Source – Behavioural Audiogram 
*Note.  Note that unknown cases may refer to those cases that are not yet determined, 
have conflicting results, or no data confirming hearing loss type, such as in cases with 
only one visit. 
 
Hearing loss type NHSF  
(n=81) 
SURV 
(n=17) 
EXT  
(n= 19) 
TRANS 
(n=14)  
REACT 
(n=20) 
Total 
(n=151) 
Bilateral       
Sensorineural 32 (45.1%) 2 (12.5%) 15 (78.9%) 7 (58.3%) 13 (68.4%) 69 (50.4%) 
Conductive 2 (2.8%) 2 (12.5%) 0 1 (8.3%) 0 5 (3.6%) 
Mixed 2 (2.8%) 2 (12.5%) 1 (5.3%) 2 (16.7%) 1 (5.3%) 8 (5.8%) 
Auditory 
neuropathy 
19 (26.8%) 2 (12.5%) 2 (10.5%) 0 1 (5.3%) 24 (17.5%) 
Different 
bilaterally 
6 (8.5%) 2 (12.5%) 1 (5.3%) 0 1 (5.3%) 10 (7.3%) 
Unknown 
bilaterally* 
10 (14.1%) 6 (37.5%) 0 2 (16.7%) 3 (15.8%) 21 (15.3%) 
Total Bilateral 71 16 19 12 19 137 
Unilateral       
Sensorineural 6 (60%) 1 (100%) 0 1 (50%) 1 (100%) 9 (64.3%) 
Conductive 4 (40%) 0 0 0 0 4 (28.6%) 
Mixed  0 0 0  1 (50%) 0 1 (7.1%) 
Auditory 
neuropathy  
0 0 0 0 0 0 
Unknown* 0 0 0 0 0 0 
Total Unilateral 10 1 0 2  1 14 
Grand total 81 17 19 14 20 151 
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Figure 3.  Bilateral Hearing Loss Type: Behavioral Audiogram. 
 
Figure 4.  Unilateral Hearing Loss: Behavioral Audiogram. 
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For those cases illustrated in Table 6 (Figures 3 and 4) with behavioural 
audiometric data, the bilateral hearing loss category includes all cases analyzed with 
hearing loss in both ears, based on the IHP data forms.  For the group with unilateral loss, 
these were cases where the IHP data form indicated hearing loss in only one ear at the 
most recent behavioural test.  Interestingly, auditory neuropathy cases bilaterally 
comprise 17.5% of the total bilaterally (24/137).   
Conductive (3.6%; n=5/137) and mixed (5.8%; n=8/137) hearing loss had 
relatively few cases bilaterally, while there were 7.3% of subjects with different hearing 
loss (type) between ears bilaterally (n=10/137).  This includes cases where hearing loss 
type in one ear is known and is unknown in the other, or, less frequently, when there is a 
different type of loss by ear.  In the bilateral group, 15.3% (n=21/137) had unknown 
hearing loss (type), at the end of the study period.  These unknown cases occur when 
behavioural testing was incomplete, responses were unreliable over the test period, or the 
data field was blank on the IHP form, and, therefore, hearing loss type could not be 
deduced from the available threshold data.   
It is clear that the majority of hearing loss cases are from the NHSF group, and 
are sensorineural, with 51.8% (n=71/137) bilateral cases and 71.4% (n=10/14) unilateral 
cases.  To note, all of the 8.5% (n=6/71) “bilateral different” cases were sensorineural in 
one ear, and unknown in the other ear.  The population with auditory neuropathy 
bilaterally consisted of 26.8% (n=19/71) children in this group, which is relatively more 
of this type of hearing loss than any of the other Referral group. 
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There were few conductive (2.8%; n=2/71) and mixed (2.8%; n=2/71) hearing 
loss cases bilaterally in the NHSF group.  For the “bilateral unknown” cases (14.1%; 
n=10/71), reasons for the unknown status included: no reliable results, or only one visit 
where hearing loss type was blank.  The NHSF group also had the majority of unilateral 
cases from the behavioural audiogram data in Table 6 (Figures 3 and 4) with 6/10 
sensorineural cases and 4/10 conductive cases. 
For the SURV group in Table 6 (Figures 3 and 4), there is an even distribution 
bilaterally across sensorineural, conductive, mixed, auditory neuropathy, and “different 
bilaterally”, all with 12.5% (n=2/16).  Also, there was one case of sensorineural unilateral 
loss.  The 12.5% (n=2/16) “different bilateral” cases in the SURV group were both 
sensorineural in one ear and unknown in the other.  Of interest are the 37.5% (n=6/16) 
“unknown bilateral” cases.  One of these cases is a child with potential auditory 
neuropathy, however, there is contradictory data, and no definitive hearing loss type is 
confirmed at the time of this analysis.  The other five cases were “unknown bilaterally” 
because there were no available thresholds (one visit only), no reliable results, or 
undetermined status still at the time of analysis.  
This led to caution in reviewing available charts for the 20 hearing-impaired cases 
under SURV, as a more conservative estimate would be 13 or 14 cases (including ABR 
audiogram data) with confirmed hearing loss type.  It is important to note that the 
hearing-impaired category also includes potentially unknown cases (still not yet 
determined for hearing loss type).  
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An assessment of the EXT group in Table 6 (Figures 3 and 4) shows that the 
majority of bilateral cases in this group are sensorineural (78.9%; n=15/19) by 
behavioural audiogram.  Out of the total of 19 cases, there is one case (5.3%) and two 
cases (10.5%) with auditory neuropathy.  There were no conductive or unknown cases 
bilaterally.  The one “bilateral different” case was one ear with mixed loss, and the other 
ear was unknown.  Unilaterally, there were no identified cases in the EXT group by 
behavioural audiogram.   
The data for the TRANS and REACT groups are similar to the other Referral 
groups in that the majority of bilateral cases are sensorineural.  There were 16.7% 
(n=2/12) “unknown bilateral” cases in the TRANS group, and 15.8% (n=3/19) in the 
REACT group.  The two cases in the TRANS group appear to have some type of hearing 
impairment but hearing loss type information is blank for both patients.  In the REACT 
group, the three cases all appear to have hearing loss but the hearing loss type is blank on 
the data forms, where there is either only one visit, or the patient could not be tested.  The 
TRANS group had two cases of unilateral loss and the REACT group had one case with 
unilateral loss. 
Table 7, and corresponding Figures 5 and 6, all show the data for cases where 
there was only ABR audiogram data available.  Again, the majority of cases are 
sensorineural (32.4%; n=22/68), and “different bilateral” (29.4%; n=20/68), or “unknown 
bilaterally” (16.2%; n=11/68).  These cases, with ABR threshold data only, should be 
considered preliminary and hearing loss type remains to be confirmed for these children.  
Again, the NHSF group comprises the majority of those subjects with ABR only (69.1%; 
n=47/68).   
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Table 7 
Hearing Loss Type by Referral Groups- ABR audiogram only 
*Note.  Note that unknown cases may refer to those cases that are not yet determined, 
have conflicting results, or no data confirming hearing loss type, such as in cases with 
only one visit. 
 
Hearing loss type NHFS 
(n=47)  
SURV (n=3) EXT (n=8) TRANS 
(n=5) 
REACT 
(n=5) 
Total 
(n=68)  
Bilateral       
Sensorineural 14 (32.6%) 2 (66.7%) 3 (42.9%) 2 (40%) 1 (20%) 22 (34.9%) 
Conductive 1 (2.3%) 0 1 (14.3%) 0 0 2 (3.1%) 
Mixed 2 (4.7%) 0 1 (14.3%) 0 1 (20%) 4 (6.3%) 
Auditory 
neuropathy 
3 (7.0%) 0 0 0 1 (.20) 4 (6.3%) 
Different 
bilaterally 
17 (39.5%) 0 1 (14.3%) 2 (40%) 0 20 (31.7%) 
Unknown 
bilaterally* 
6 (14.0%) 1 (33.3%) 1 (14.3%) 1 (20%) 2 (40%) 11 (17.5%) 
Total Bilateral 43 3 7 5 5 63 
Unilateral       
Sensorineural 3 (75%) 0 0 0 0 3 (60%) 
Conductive 0 0 1 (100%) 0 0 1 (20%) 
Mixed  0 0 0  0 0 0 
Auditory 
neuropathy  
0 0 0 0 0 0 
Unknown* 1 (25%) 0 0 0 0 1 (20%) 
Total Unilateral 4 0 1 0 0 5 
Grand total 47 3 8 5 5 68 
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Figure 5.  Bilateral Hearing Loss Type: ABR Audiogram Only. 
 
Figure 6.  Unilateral Hearing Loss Type: ABR Audiogram Only. 
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3.2.5 Hearing Loss Severity 
Table 8 shows the degree of hearing impairment using a common pediatric 
classification system in which the categories range from normal hearing to profound 
hearing loss (Clark, 1981).  Results are shown using PTA3 according to Clark (1981) and 
PTA4 for comparison, since this is often used in published studies.  Note that “ABR 
only” audiogram data were not included.  The two PTAs provide similar results; the most 
significant hearing losses (all from moderate to profound categories) account for 
approximately two-thirds of the hearing-impaired sample. Also, there is one normal 
hearing case looking at PTA3, however, according to PTA4, the child is classified with 
slight hearing loss.   
Table 8 
Degree of Hearing Impairment 
Classification Hearing level 
(dBHL) 
Number of 
subjects  using 
PTA 3  
(n=93)               (%) 
 
Number of subjects 
using PTA 4  
(n=79)                  (%) 
 
Normal hearing -10 to 15 1 1.1 0 0 
Slight hearing loss 16 to 25 10 10.8 10 12.7 
Mild hearing loss 26 to 40 20 21.5 15 19.0 
Moderate hearing 
loss 
41 to 55 23 24.7 22 27.9 
Moderately severe 
hearing loss 
56 to 70 19 20.4 16 20.3 
Severe hearing loss 71 to 90 12 12.9 12 15.2 
Profound hearing 
loss 
> 90 8 8.6 4 5.1 
*Note. Categories are based on the most recent behavioral audiogram pure tone averages, using 
the better ear if hearing loss is bilateral, and the worse ear if unilateral. 
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Figure 7 shows the degree of hearing impairment by Referral groups for both 
PTA3 and PTA4.   As noted above, approximately two-thirds of cases fall in the 
categories of moderate hearing loss or worse.  By Referral group, EXT and TRANS have 
the highest proportion of cases in the moderate–to profound range of hearing loss, while 
the frequency of this degree of hearing loss in children under audiological surveillance is 
much lower (SURV: PTA3 at 20%; n= 2/10).  It is clear from Figure 7 (and Appendix I) 
that the NHSF group has the majority of hearing-impaired cases.  Within the NHSF 
group, and based on the PTA3 data (n=44/93), both moderate (29%) and mild (23%) 
hearing loss are predominant, followed by moderately severe (16%), slight (14%), and 
profound (14%) hearing loss.  Therefore, the degree of hearing loss was distributed 
evenly in the NHSF group, and likewise for the TRANS and EXT Referral groups.  
Interestingly, there was one child listed with normal hearing looking at PTA3 data (slight 
hearing loss when looking at PTA4).  This case is based on the most recent visit with 
PTA data, but the child did return for a subsequent visit, and it appears there is a slight 
hearing loss but results were not reliable, and no PTA data were available for that visit.     
The SURV group is the Referral group with the most cases of mild hearing loss, 
as well as moderate hearing loss, both at 30% with PTA3 data; results are similar for 
PTA4.  This could indicate that these mild hearing loss cases are not being picked up at 
newborn screen but would be captured through subsequent surveillance. It is also 
possible that they were normal hearing at birth and that the hearing loss is emergent, and 
had progressed to a mild loss at the time of assessment. The results for SURV cases with 
a slight hearing loss, (10% with PTA3 data; 8% with PTA4) also support this possibility.  
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Moderately-severe and profound hearing loss degree categories are both 10% of this 
group of ten children using PTA3 data.  
The TRANS group has the majority of their cases looking at PTA3 data with 
moderately severe hearing loss (34%), followed by moderate and severe hearing loss, 
both 22%.  Profound and mild hearing loss accounted for 11% each.  The data with PTA4 
show a larger proportion with moderately severe hearing loss (45%) compared to PTA3.     
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Figure 7.  Degree of Hearing Loss by Referral Groups. 
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3.2.6 Age 
The age (months) of the most recent, complete behavioural audiogram is shown in 
Figure 7, for the following test frequencies: 0.5 KHz, 1 KHz, 2 KHz, 4 KHz.  The sample 
size varies by frequency because not all cases had all frequencies tested.  Cases with only 
ABR data are not included. The scatterplots show that all degrees of hearing loss are 
identified, irrespective of age at the final (most recent) behavioural audiogram.   
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Figure 8.  Threshold Data by Age for Most Recent Behavioral Audiogram. 
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3.2.7 Symmetry 
Ear symmetry is based on comparisons of the left ear versus right ear thresholds, 
as shown in Tables 9 and 10, and in Figure 9.  Scatterplots were analyzed, and correlation 
coefficients are shown in Figure 9.  The scatterplots indicate that most individuals have 
symmetrical hearing loss, although more variation and a lower correlation coefficient is 
shown for the 4 KHz threshold data. 
Tables 9 and 10 provide insights into how hearing level asymmetry varies by type 
of test and by Referral group.   From Table 9, it is clear that the 2 KHz and 4 KHz test 
results show a greater proportion of asymmetry cases.  The other test types and PTAs are 
similar in the extent to which they provide lower proportions of asymmetry cases.  The 
numbers in brackets in Table 10 show the number of cases in each category although not 
all cases have all four frequencies tested.  However,   19 cases have 14 such cases (74%), 
with the second group having 17/25 or 68%.  The lowest proportion is for the SURV 
group, where the 20 cases record only three asymmetries (15%). 
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Table 9 
Cases with Asymmetry at Different Frequencies and PTA3 and PTA4 
  
  
  
  
  
Note. Asymmetry is defined as a difference of > 20 dB between both ears.  STDEV = 
3.79%. 
Table 10 
 Asymmetry Cases by Frequency and Referral Type 
Frequency EXT (n=9) REACT 
(n=17) 
 
SURV (n=3) TRANS (n=14) NHSF (n=51) 
0.5 KHz 2 (22.2%) 3 (17.6%) 0 (0.0%) 2 (14.3%) 9 (17.6%) 
1 KHz 2 (22.2%) 2 (11.8%) 1 (33.3%) 2 (14.3%) 6 (11.8%) 
2 KHz 3 (33.3%) 4 (23.5%) 1 (33.3%) 3 (21.4%) 13 (25.4%) 
4 KHz 0 (0.0%) 4 (23.5%) 1 (33.3%) 3 (21.4%) 10 (19.6%) 
PTA 3 1 (11.1%) 2 (11.8%) 0 (0.0%) 2 (14.3%) 7 (13.7%) 
PTA 4  1 (11.1%) 2 (11.8%) 0 (0.0%) 2 (14.3%) 6 (11.8%) 
Perfect symmetry would consist of scatterplots in which all points fall on the 45 
degree line (RE=LE).  Greater degrees of dispersion and outliers indicate greater 
asymmetry.  Greater asymmetry is apparent for the cases of IHP reactivation (REACT 
group) and IHP transfer cases (TRANS).  
 
 
Frequency Cases with 
asymmetry  
Total (n) % with 
asymmetry 
0.5 KHz 16 124 12.9% 
1 KHz 13 96 13.5% 
2 KHz 24 125 19.2% 
4 KHz 18 83 21.7% 
PTA 3 12 93 12.9% 
PTA 4 11 79 13.9% 
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  Figure 9. Symmetry Plots at 0.5KHz, 1KHz, 2KHz, 4KHz, PTA3, and PTA4. 
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Figure 9. Symmetry Plots at 0.5KHz, 1KHz, 2KHz, 4KHz, PTA3, and PTA4. 
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Chapter 4  
4 Discussion 
4.1 Introduction 
          Most developed countries, including Canada, have implemented EHDI programs, 
including universal newborn hearing screening.  The literature shows that language 
development is positively and significantly affected by the age of identification and of 
intervention services (Yosinago-Itano, 1998).  This critical period for early language 
development is within the first six months of life (Yoshinago-Itano, 2003). 
Universal newborn hearing screening and EHDI programs result in earlier 
diagnosis of hearing loss and early detection enables early intervention services for 
affected families. Earlier generations of children could be identified as late as two and a 
half years of age, after significant developmental opportunities have passed (Yoshinago-
Itano et al., 1998).   
The current audiological standard is to complete the hearing screening in all 
infants by one month of age, followed by audiological assessment by three months of age 
in those identified as at-risk for hearing loss based on the screening outcome, and 
targeted risk factors, depending on geographical location (JCIH, 2007).  For infants with 
confirmed hearing impairment, intervention should begin by six months of age 
(Yoshinago-Itano, 2003).   
The JCIH recommends that all infants with certain risk factors for other speech or 
language impairments should be under surveillance for long-term communication 
development (JCIH, 2007).  These at-risk children receive universal neonatal newborn 
hearing screening, and in addition, should have ongoing medical, speech, language, and 
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audiological surveillance through their medical “home”.  It is considered important that 
infants who pass neonatal screening, but have one or more risk factors for hearing 
impairment such as low birth weight, have at least one diagnostic audiological 
assessment by 24 to 30 months of age.   However, the evidence to support these 
recommendations is generally lacking and a recent study by Beswick et al. (2012) argues 
that there is a need to examine the effectiveness of newborn screening and surveillance 
programs through data review and data sharing across infant hearing programs.  
4.2 Insights from the Literature 
The literature reviewed in Chapter 1 is extensive.  Key findings in summary form 
are: 
 Early detection is critical.  Earlier identification of hearing loss leads to 
better results in communication, educational achievement, and social 
development in children. 
 UNHS is carried out in Canada and in most developed countries.  Its use 
has dramatically improved outcomes for infants with hearing loss at birth.   
 Most, but not all cases of hearing issues are detected by UNHS.  
Postnatal hearing impairment is complex.  Little is understood about 
the numbers and features of infants who develop significant hearing 
loss even after passing initial newborn hearing screening.   
 Identifying those children who develop hearing problems after 
passing the initial newborn screening is recognized as a serious 
challenge in the field of audiology.  The data from large databases of 
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universal neonatal hearing screening programs could be useful for 
establishing practice and policy for children with different hearing 
loss outcomes, including progressive and emergent postnatal hearing 
loss.   
There are only a few early detection programs that currently have the capacity to 
report the number of infants screened, assessed, surveilled, and registered in intervention 
programs. Moreover, there is a need for evidence-based research to determine the cost 
effectiveness of dealing with specific surveillance and risk factors because the cost of 
audiological assessment is a policy factor in determining the feasibility of monitoring 
services.   
A comparison of hearing outcomes across populations that have different risk 
levels is needed to improve screening and assessment. For example, these populations 
include infants who pass or fail newborn screening and those with and without protocol 
defined risk factors.  The major contribution of this thesis is in providing a detailed 
description of the comprehensive data set of children from the Ontario IHP screening and 
surveillance program at the H.A. Leeper Clinic site. 
4.3 Research Question 1: Identification of Hearing 
Impairment 
It was hypothesized that the Referral groups (referral route to IHP) will be related 
to the hearing assessment outcomes (presence/absence; category and degree of hearing 
disorder). A specific aim of this study was to look at hearing outcomes in terms of 
hearing loss present or absent (ie. normal hearing) for the entire population, and for the 
five different Referral groups.  From the total of 2,638 children enrolled at this site, 2,390 
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were determined to have normal hearing by audiological assessment (full diagnostic and 
surveillance testing).  Of interest, and with potential further consideration, is the 
considerable difference between the number of hearing impaired cases that were 
identified as male (62.9%; n=156) versus female (37.1%; n=92) in this thesis.   
As per the meta-analysis of Fortnum (2003), the proportion of males to females 
identified with permanent childhood hearing impairment.  This allowed for a calculation 
of an overall gender ratio for impairment >40dB of 1.16/1.0 (Fortnum, 2003).  It is not 
clear why the proportion (1.70/1.0) of males to females is much higher in this thesis.  If 
gender is consistently predominantly male across research studies for those who are 
screened and develop hearing loss, this could affect practice and policy in the future.  
The detection of hearing loss was also examined within each of the five Referral 
groups.  Infants who failed newborn screening (NHSF), or infants who are recommended 
for surveillance based on the presence of at least one IHP defined risk factor (SURV), or 
who are referred externally (EXT), reactivated (REACT), or transferred (TRANS), all are 
eligible to receive IHP services.  
4.3.1.1 NHSF Referral Group Hearing Outcomes 
The majority of the cases identified with hearing loss were those children who 
were NHSF, and therefore had been referred to the IHP with a “refer” result from 
screening in at least one ear (57.7%; n=143).  It is important to note that 15.1% (33/219) 
of cases labeled “hearing impaired” by manual review were actually cases for which 
hearing loss type was not yet identified, or unknown.  The other 29 charts were not 
available for manual confirmation and were therefore excluded.  Therefore, caution 
should be exercised in basing conclusions solely on the electronic database. 
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  It was expected that the majority of the cases that developed hearing impairment 
would have been in the NHSF Referral group, despite the presence or absence of a risk 
factor.  Out of 693 NHSF referrals (failed UNHS), 143 children did develop hearing 
impairment.  However, 79.4% (n=550) children, of the NHSF referred children had 
normal hearing, which is why it is important to be mindful of how to approach the results 
of initial screening with parents and caregivers, to alleviate anxiety (Hyde, 2005).   
However, considering data that in hospitals with newborn screening compared to 
hospitals without screening, 84% who received screening were identified prior to six 
months of age as recommended, while only 8% were detected prior to six months in 
hospitals without screening (Yoshinago et al., 2001).  This demonstrates the benefits of 
universal screening for developmental outcomes, especially beneficial for those who fail 
newborn screening (NHSF).   
This thesis reported data from the NHSF group, where 693 children failed the 
screen, and subsequently 20.6% (n=143) were identified with permanent childhood 
hearing impairment.  Another study that examined a group of screened children was 
conducted by Mason and Herrmann (1998).  All of the newborns (n=10,372) were 
screened in the nursery.  In this sample, 415 of these children failed screening, and a 
subsequent 3.6% (n=15) children were then identified with a permanent childhood 
hearing impairment (Mason & Herrmann, 1998).  Interestingly, a similar study by 
Barsky-Firsker and Sun (1997) showed results of 10.7% (n=52) from a total of 485 
children who failed their screen. It is not clear from the literature why the incidence of 
permanent hearing impairment is lower in the Mason and Herrmann study.   
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4.3.1.2 SURV Referral Group Hearing Outcomes 
A main point that was noted from the data described in Figure 2 is that the 
majority of the children referred to the H.A. Leeper Clinic for IHP services from 
implementation in 2002-2011 were in the SURV group.  That means that a total of 1,559 
children were assessed who were referred because they had at least one IHP protocol 
defined risk factor. Out of the 1,559 referred for SURV, 23 SURV cases were identified 
from the electronic database as hearing-impaired (1.47%; n=23).  There were 20 of these 
23 charts in the SURV group available for manual review to check for confirmed hearing 
impairment.  There were seven cases upon manual chart review in the SURV group that 
were still not determined for hearing loss type, however, it is apparent from the threshold 
data that there is some type of hearing impairment for three of the seven cases.  One case 
was a query for auditory neuropathy, whereas the other two children were queries for 
sensorineural loss.  The remaining four cases had insufficient visit and threshold data, as 
well as incomplete hearing loss type data from the IHP data forms available.   
Therefore, it can be said with more certainty that there are closer to 17/20 SURV 
children based on chart review with some type of identified hearing impairment.  This 
would give a rate closer to 17/1,556= 1.09% detected by surveillance for the entire SURV 
group referred in the time frame of this thesis.   
A study recently published by Beswick et al. (2012) is the only other known 
large-scale study examining surveillance monitoring outcome data.  The goal of the 
researchers was to describe a targeted surveillance program using risk factors.  Beswick 
et al. (2012) had available a comprehensive risk factor registry, whereas this thesis was 
only able to account for the presence or absence of at least one risk factor.  During their 
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study period from September 2004-December 2009, 7,320 children were referred for 
targeted surveillance after passing newborn screening.  They found that 0.77% (56/7,320) 
were identified with postnatal hearing loss (this is the rate of postnatal loss) (Beswick et 
al., 2012).   
This thesis has a similar time frame, from 2002-2011, although our catchment 
area was smaller, and we had a total of 1,559 children referred to the H.A. Leeper Clinic 
for surveillance monitoring, although we examined all Referral groups.  While comparing 
the results of this thesis with those of Beswick et al. (2012), this thesis had a postnatal 
hearing loss rate of 1.48% (23/1,559).  These data are from the electronic database and, 
therefore, may be a slight overestimate of the total confirmed cases of permanent 
childhood hearing impairment, if some of these cases were still not fully determined. 
 Another interesting study by Johnson et al. (2005) concluded that of 21 infants 
who had failed the otoacoustic emissions (OAE) testing but had passed their automated 
brainstem response (ABR) audiometry during newborn screening developed either 
bilateral, or unilateral permanent hearing impairment, identified around nine months of 
age.  These researchers show that many of these cases are milder hearing loss and that 
many of the machines used are designed to identify moderate or greater hearing loss 
(Johnson et al., 2005).  They recommend more surveillance during childhood.   
The results from this thesis, which has a higher rate of detected postnatal hearing 
impairment than found by Beswick et al. (2002) suggest that ongoing surveillance and 
improved surveillance program evaluation would be useful for improving hearing 
outcomes. 
61 
 
4.3.1.3 EXT, TRANS, and REACT Referral Group Hearing 
Outcomes 
The EXT group included 11.3% (n=28), TRANS with 8.9% (n=22), and REACT 
had 12.5% (n=31) of the hearing-impaired sample from the electronic database.  These 
groups are relatively evenly distributed and have more variability in their definition of 
referral routes.  For example, a REACT case could include a child who originally passed 
UNHS without a risk factor, or who originally passed, with a risk factor, and was cleared 
after surveillance.  The child could be later reactivated due to concern.  Conversely, a 
TRANS case is transferred within the IHP region but identified by another IHP region, 
and therefore, there is limited knowledge of these cases in terms of their original referral 
information. Finally, the EXT group could be anyone with screening results unknown, or 
who moved from outside the country.  Other situations for the EXT group could include 
cases in which the child was born prior to newborn screening implementation.  These 
EXT cases are referred due to some kind of concern, or due to the absence of any initial 
screening.  Therefore, EXT, REACT, and TRANS groups in this thesis are less 
generalizable than the NHSF, or the SURV group. 
4.3.2 Hearing Loss Presence/Absence and Hearing Risk Factor   
The risk factor data results were not the main focus of the research questions but 
are of interest because it is useful information, especially in looking at incidence with the 
hearing-impaired population.  For example, a study by Mehl and Thomson (2002) 
identified 291 children with congenital hearing loss in The Colorado Newborn Hearing 
Screening Project from 1992-1999.  In this study, 47% of the 291 children were identified 
with at least one risk factor.  Additionally, the study also looked at cases from the year 
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1999 specifically.  In this year, 86 children were identified with hearing loss, and 32 of 
the 86 children were identified with having at least one risk factor, showing the 
importance of non-targeted universal screening (Mehl & Thomson, 2002).  This thesis 
found that 66.1% of the hearing-impaired group was identified with at least one risk 
factor (n=164/248), which is slightly higher than the described study by Mehl & 
Thomson (2002). 
     A limitation of this thesis was the fact that hearing risk factor data were based on 
the definition of presence or absence of at least one risk factor, with no specific details 
provided.  However, given this caveat, in the hearing-impaired group, 66.1% had at least 
one risk factor (n=164/248), in contrast to the normal-hearing group, where only 46.2% 
had the presence of at least one risk factor, based on the electronic database.  This thesis 
also shows that, as expected, there is substantial variation in the presence of risk factors 
by Referral group.  For those children referred from NHSF, a large majority (74.2%) 
were identified with at least one risk factor.  This is again a much larger number than 
seen in the study by Mehl and Thomson (2002).  It would be helpful to know more 
detailed risk factor data, such as a comprehensive list of risk factors as a necessary 
component of the IHP protocol, and to have this documented in the IHP database. 
Also of importance is that every child in the SURV group had at least one IHP 
protocol risk factor, which is why they were referred to the IHP Surveillance Program.  
The risk factor data are incomplete for the normal hearing group based on the electronic 
database, and those cases were listed as unknown.  This was 48.7% of the total sample 
with risk factor data incomplete from the electronic database.  An article by Mason, 
Gaffney, Green, and Grosse (2008) shows that there is a need for standards for reporting 
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results in EHDI programs overall.  It was taken into account that those cases in the IHP 
SURV group should have been considered to have at least one risk factor by definition, 
despite the large number of unknown cases (incomplete data entry), for the normal 
hearing group, based on the electronic database. 
The EXT group had just over half (55.6%) identified with at least one risk factor 
while the IHP transfer hearing-impaired cohort had 57.9%.  For the IHP group that was 
reactivated, 47% of the cases had at least one risk factor.  These three Referral groups are 
again more difficult to generalize because of the various different ways that the children 
are transferred or referred.  It is therefore expected that there will be more variability than 
with the NHSF and SURV groups.  There is also no known study that has broken down 
the Referral groups in this manner. 
4.4 Research Question 2: Nature of Hearing Loss 
             Research Question 2 focuses on the details of the hearing impairment for the 
hearing-impaired subjects, and the analysis evaluates these results according to the 
referral route into the IHP.  Among the 248 hearing-impaired children identified via the 
electronic database, a detailed analysis of the clinical charts was conducted in order to 
evaluate the nature of the hearing impairment in each subject, and is discussed in the 
context of the Referral groups.   
4.4.1 Hearing Loss Type 
The literature describes three main types of hearing loss: sensorineural, 
conductive, and mixed.  In addition, this thesis presents data on auditory neuropathy, 
which has been included in targeted permanent childhood hearing loss since the JCIH 
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2007 guidelines (JCIH, 2007).  This thesis measures the extent of variation in hearing 
loss by Referral group.  To briefly summarize the results shown in the thesis, for all 
groups, the “bilateral same” category for sensorineural hearing loss has the largest 
number of cases and conveys the best overall picture when comparing hearing loss across 
categories.  Most neonatal hearing loss is sensorineural, and a known genetic cause is 
found in 50% of these children, as described by Patel and Feldman (2011), and our 
results are similar. 
Additionally, it is noted that there are substantially more bilateral cases (n=200) 
compared to unilateral (n=19) and this is clear across Referral group categories, and most 
pronounced in the NHSF, as expected.  Additionally, there is a relatively high proportion 
of conductive hearing loss unilaterally, which could be due to structural abnormalities, 
such as microtia.  Auditory neuropathy is most common in the NHSF group with 23 cases 
out of the 29 identified.  It would be interesting to examine how many of these cases were 
Newborn Intensive Care Unit (NICU) cases, although these specific risk data were not 
available.  
There were a relatively large number of cases where the data from the IHP form 
in the charts were “unknown” bilaterally.  There was a total of 32 cases with “unknown 
bilaterally”.  This can be misleading because there are different scenarios where there is 
threshold data that indicate hearing impairment, but the hearing loss type is not yet 
confirmed, or the IHP form was left blank, and perhaps the type was, in fact, known.  
Other reasons include conflicting data, one visit only data, a blank field for hearing loss 
type, or something is being queried, however, not yet confirmed.  For the “different 
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bilaterally” cases, the majority are where one ear is defined, while the other is unknown.  
The same reasons as above apply for why this may be unknown. 
Using the “Bilateral same: Behavioral Audiogram” category, the lowest incidence 
of (sensorineural +conductive+ mixed) divided by total category cases is recorded for the 
NHSF and for the SURV group (0.28 and 0.30).  The other three categories are much 
higher, all falling in the range from 0.53 to 0.59. When including auditory neuropathy as 
a fourth hearing loss category, the incidence by referral category is: 
• NHSF; (55/128, 0.43) 
• TRANS (10/19, 0.53) 
• SURV (8/20, 0.40) 
• REACT (15/25, 0.60) 
• EXT (18/27, 0.67). 
This shows that NHSF and SURV continue to have the lowest incidence rates but the 
difference is smaller. 
4.4.2 Severity of Hearing Loss  
Although incidence data for hearing loss are important, the severity of the loss is 
likely a more important indicator of impact.  This thesis shows the degree of such loss in 
total and by Referral group using both PTA3 and PTA4 data and using Clark’s (1981) 
criteria.  Although PTA3 is used more commonly, PTA4 data were also included for 
comparison with PTA3. Overall, both PTA3 and PTA4 show a significant hearing loss 
(all from moderate to profound) for approximately two-thirds of the cases.   
Overall, the majority of cases were moderate hearing loss, followed by 
moderately-severe.  Of importance, the mild and slight hearing loss groups comprise 
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32.3% of the overall sample here with PTA3 data.  The SURV group included 10 cases 
with PTA3 data and 8 cases with PTA4 data.  The SURV group is the Referral group that 
had the most cases of mild hearing loss, as well as moderate hearing loss, both at 30% 
with PTA3 data; results are similar for PTA4.  This could indicate that these mild hearing 
loss cases are not being picked up at newborn screen but would be captured through 
subsequent surveillance. It is also possible that they were normal hearing at birth and that 
the hearing loss is emergent, and had progressed to a mild loss at the time of assessment. 
There is significant evidence that both slight and mild hearing loss can have large effects 
on language development as well, and this group could benefit from improved efforts in 
identification and management of hearing loss (Bess, Dodd-Murphy, & Parker, 1998). 
In assessing the degree of hearing impairment by Referral groups for both PTA3 
and PTA4 data, this thesis shows that both EXT and TRANS Referral groups have the 
highest proportions in these categories with 0.71 and 0.77 (EXT PTA3 and PTA4) and 
with 0.89 and 0.89 for TRANS. The lowest severity (at 0.5 for both PTA3 and PTA4) is 
in the SURV group. If the focus is only on the two most severe categories (severe and 
profound), the same two categories have relatively more of these cases.  
Based on Referral groups and by looking at PTA3, it is apparent that there are 
more moderate hearing loss cases in general across groups.  An interesting point is that 
compared to PTA4, there are many fewer profound hearing loss cases looking at PTA3.  
This could have clinical implications for deciding upon severity criteria, as PTA3 data is 
commonly used as a standard, but perhaps there should be more investigation into the 
differences between PTA data .   
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Another puzzling finding is that the greatest degree of profound loss by Referral 
group is in the EXT group with PTA3 data (21%).  This is considerably more than any 
other group looking at PTA3 or PTA4.  However, the EXT group with profound loss 
looking at PTA4 drops to 8%.   
Both the TRANS and REACT groups have a larger proportion of moderately 
severe loss, with 34% and 37%, respectively.  However, the NHSF group trended 
towards a higher proportion with moderate (29%, PTA3; 34% PTA4) hearing loss and 
mild hearing loss (23% PTA3; 20% PTA4).   
4.4.3 Hearing Loss Symmetry  
Hearing loss symmetry is based on comparisons of left ear versus right ear, with 
asymmetry defined as a difference of >20dB between both ears (Pittman & 
Stelmachowicz, 2003).  This thesis provides important insights into this issue using both 
tables and scatterplots. Asymmetry is of importance clinically with binaural amplification 
implications.   
Symmetry scatterplots (RE vs. LE) show a very high association in terms of 
symmetry, with more variation at 2 and 4 KHz.  The 2 KHz and 4 KHz test results show 
a greater proportion of asymmetry cases, and is consistent with other research (Pittman & 
Stelmachowicz, 2003). 
The other four test types are similar in the extent to which they provide lower 
proportions of asymmetry cases.  By Referral group, it is clear that the TRANS group 
(74%) and the REACT (68%) have the greatest degrees of asymmetry.  The lowest 
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proportion is for the SURV where there were only three asymmetries (15%).  These 
findings are shown clearly and consistently in the tabulations and scatterplots.   
The REACT group might have been cases of progressive or mild hearing loss in 
one ear, and therefore, originally passed screen.  This might be a reason for more 
asymmetry seen in this Referral group.  There are, however, no consistent data in the 
TRANS group and due to sample sizes, it is difficult to make any concrete conclusions.    
4.4.4 Hearing Loss Age 
This thesis also examined the impact of age of the child on the various hearing 
frequencies. Age (in months) was then plotted against frequencies and provides age range 
data for referencing the data. Only the most recent (and most complete) behavioral 
audiogram data were used for each of the hearing-impaired cases.  ABR only audiogram 
cases were excluded.  Scatterplots and simple correlation coefficients show that the 
degree of association was extremely low in all cases.  As a result, this thesis does not 
focus on age issues which appear to not be a statistically significant factor.   
4.5 Limitations of Study 
This study is based on data from an extensive database at the H.A. Leeper Speech 
and Hearing Clinic.  The database at this IHP site is manually entered. The presence of 
blank data for the normal hearing group, especially for gender and presence or absence of 
a risk factor limited the usefulness of these data upon review from the electronic 
database.  This is a common problem with electronic databases and data entry compliance 
has been similarly cited by Beswick et al. (2012) and the need for standards is stated by 
Mason et al. (2008).  Also, despite best efforts, there were 29 charts out of 248 that could 
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not be located in the archives.  That left 219 charts with hearing impairment that were 
available for review.  It is recognized that any unknown data will affect attrition bias, and 
it is assumed there will be some human error from data extraction to data entry, although 
this is not viewed as a significant limitation. 
There were also limitations in analyzing risk factor data, due to the definition 
which can only reliably say whether there was the presence of at least one risk factor.  A 
future goal for the IHP would be to incorporate a comprehensive list that must be 
checked off based on protocol defined risk factors and that all of these are entered in the 
electronic database.   Data were manually extracted for risk factors for the hearing loss 
patients through chart review (confirmation of at least one risk factor), although there 
were many unknown risk data from the electronic database.  The charts for the normal 
hearing cases were also archived and there were 2,390 cases, which were out of the scope 
of this thesis for manual review.  However, referral groups were captured almost entirely 
for the entire study sample. 
In addition, the IHP data forms were not always consistently checked off in every 
visit for different fields, such as hearing loss type.  This is why it was chosen to use the 
most recent behavioral test when available to define hearing loss type or for choosing 
PTA data for hearing loss severity and symmetry.  Conversely, ABR audiogram only data 
limited our analysis of the data and were thus kept separately as to not imply that more 
reliable testing was performed.  ABR only data were thus not used in determining the 
hearing loss severity and symmetry, and kept separate for hearing loss type. 
70 
 
Hearing loss features have many different classification systems, and depending 
on the chosen methodology, this can affect the interpretation of results.  Therefore, 
Clark’s (1981) ASHA accepted criteria were chosen for hearing severity and comparing 
PTA3 and PTA4 data for contrast, and the NIH (2008) Pittman & Stelmachowicz (2003) 
criteria were chosen for asymmetry.  It is our hope that further research using these data 
will provide more insight into other features of hearing loss in this sample. 
Finally, it is noted that the electronic database showed that there were 23 hearing- 
impaired cases for the SURV group.  However, this does not take into account those 
cases that are still not yet determined for hearing loss type, and are still being assessed.  
After further manual review as described in Chapter 3, it is estimated that it is more likely 
that there were 17 cases with determined PCHI in the SURV group.  This difference has 
an effect on how the Surveillance Program is evaluated and its impact on policy. 
4.6 Insights for Policy 
The different routes that children take to enter the IHP have an important impact 
on how we look at program evaluation and its effects on policy makers.  This thesis is 
one of the largest scale studies that examines targeted Surveillance Programming, 
however, the recent study by Beswick et al. (2012) also described a targeted surveillance 
program.  In their findings, they found a lower rate of hearing loss detection through 
surveillance at 0.77% (56/7,329).  In this thesis 1.48% 23/1,559 SURV children were 
confirmed with hearing loss by the electronic database. 
Among their conclusions, Beswick et al. (2012) state that the limitations of the 
program bring into question its usefulness.  They suggest that better time frames are 
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needed for assessment, assessments performed, and that discharge criteria all need to be 
revisited (Beswick et al., 2012).   
Similarly, this thesis may have also experienced the same challenges and, in 
addition, the majority of cases that were assessed in the IHP at the H.A. Leeper Clinic 
were surveillance and normal hearing cases.  This thesis did find a slightly higher rate of 
hearing impairment in our surveillance group compared to the findings of Beswick et al. 
(2012).   
A cost benefit perspective may be useful in considering the current Surveillance 
Program for the OIHP, with further studies looking at the effectiveness of this program.  
One possible option might be to move towards a two stage screening process, which 
would reduce the cost elements of the Surveillance Program.  Weichbold et al. (2006) 
concluded from their study that because some children do not have the targeted risk 
factors or any at all, another screening around preschool may capture these postnatal 
hearing loss cases best.   However, this change to the IHP would be costly requiring 
another entire round of screening.  In terms of improving community awareness, research 
programs investigating compliance, standardizing reporting results, and program 
awareness by physicians, families, and appropriate timepoints in surveillance would also 
be useful.   
The overall conclusion of this thesis is that the IHP electronic database at the H.A. 
Leeper Clinic provides a unique insight into the effectiveness of the Surveillance 
Program.  However, one recommendation is that the data capture process at the IHP 
clinic level at Western University should include all information in the clinic charts, and 
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that the data should be digitized.  Electronic management of these data would also ensure 
that complete referral data, in addition to all details regarding risk factor were captured.  
This would allow a more feasible way to measure program impact and facilitate research 
into the epidemiology of permanent childhood hearing impairments as well as hearing 
intervention outcomes.    
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Appendices  
Appendix A: IHP Assessment Criteria 
Auditory Brainstem Response (ABR)-based Assessment  
1. Compliance with IHP test parameters.  
2. Selection and sequencing of stimulus type, frequency and intensity.  
3. Branching to 1 kHz, 4 kHz and AN sub-protocol where indicated.  
4. Size and replication of averages.  
5. Accuracy of response detection decisions.  
6. Appropriateness of EHL estimates.  
7. Appropriateness of hearing loss type and severity inferences.  
8. Consistency between records and IHP report form.  
9. Consistency between records and any textual report.  
10. Appropriateness of test strategy across multiple test sessions (if applicable).  
11. Timeliness of multiple test sessions (if applicable). 
Visual Reinforcement Audiometry (VRA)-based Assessment  
12. Compliance with IHP Protocol for VRA such as the following:  
a. Evidence of 2 consecutive conditioning trials to establish that the infant in 
conditioned prior to initiating threshold search  
b. Evidence of "bracketing" e.g. at least one (-) below MRL when MRL is considered 
to be established at an elevated (greater than 30dBHL) level.  
c. Evidence of bone conduction threshold attempts and intervening frequency 
threshold attempts where indicated.  
d. Evidence of MRL established for at least 0.5 KHz and 2 KHz for both ears (i.e. 
assessment is 'finished')  
e. Evidence of a control trial strategy to ensure a reliability of at least 70%  
f. A reliability score of 70% or better evident in each complete assessment  
g. If the reliability score is less than 70%, documentation of an attempt at 
reassessment should be present (i.e. assessment is 'not finished').  
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13. Appropriateness of hearing loss type and severity inferences.  
14. Consistency between records and IHP report form.  
15. Consistency between records and any textual report.  
16. Appropriateness of test strategy across multiple test sessions (if applicable).  
17. Timeliness of multiple test sessions (if applicable). 
Distortion Product Otoacoustic  Emissions (DPOAE)  
18. Compliance with IHP test parameters  
19. Constancy of autocalibrated stimulus levels.  
20. Replication where indicated.  
21. Consistency between records and IHP report.  
22. Consistency between records and any textual report.  
Middle Ear Audiometry (MEA)  
23. Correct probe frequency.  
23. Repetition of tympanogram where indicated.  
24. Appropriate reflex stimulus levels and repetitions.  
25. Consistency between records and IHP report.  
26. Consistency between records and any textual report. 
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Appendix B: IHP Definitions of Normal Hearing and Permanent Childhood 
Hearing Impairment 
IHP Normal Hearing Definition 
From the IHP perspective, hearing is ‘normal’ when the target disorder is deemed not to be 
present. This is not the same thing as the conventional, clinical meaning of ‘normal hearing’. 
In ABR-based Assessments, clear and reproducible ABRs by air conduction at 0.5 kHz and 
2kHz in each ear at the mandatory minimum levels are sufficient to define ‘normal’ hearing 
from the IHP perspective. If any other frequency is tested for any reason, a similar result is 
required. In VRA-based and CPA-based Assessments, a similar inference applies, but only if 
the VRA thresholds obtained are ear-specific.  
Because there are many causes of absent or depressed DPOAEs, normality of OAEs at all 
frequencies is not necessary for an overall conclusion of IHP ‘normal hearing’.  
When a ‘normal hearing’ determination is made, the family should be counseled fully about 
what exactly is meant by such a result and about the need for continued vigilance. The 
family should be provided with standard IHP documentation covering issues such as risk  
indicators, communication development milestones and actions if a concern develops. This 
information should be provided in the most relevant language available from the IHP. 
Permanent Childhood Hearing Impairment (PCHI) Present 
The infant is defined to have the target PCHI by any elevation of BC tonepip ABR threshold 
or VRA MRL of 10 dB or more above the required minimum test levels at 500 Hz or 2 kHz, in 
either or both ears. In the event that BC testing has proved unfeasible or inconclusive, AC 
threshold measurements may serve to define sensorineural hearing levels provisionally, 
provided that immittance results are clearly normal. PCHI is also deemed to be present if AC 
thresholds are clearly higher than those that could be attributed to purely conductive 
impairment. PCHI is also deemed to be present if test results indicate the presence of AD. 
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Appendix C: IHP High-Risk Indicators for Permanent Childhood Hearing 
Impairment 
Perinatal  
The following indicators a-l are usually associated with attendance in a special care nursery, 
whereas indicators m-o may arise from any nursery. ANY ONE of the indicators is sufficient 
to place the baby at risk. Perinatal indicators are sought by screening personnel, other 
hospital staff, and the child’s physician(s).  
At initial Assessment, audiologists should review risk status and should seek risk indicators 
in children presenting as not at risk. New risk information may arise at any time throughout 
the child’s progression through IHP services.  
a. Birthweight less than 1200 grams  
b. Five-minute APGAR score less than or equal to 3  
c. Congenital Diaphragmatic Hernia (CDH)  
d. Persistent Pulmonary Hypertension of the Newborn (PPHN)  
e. Hypoxic-Ischemic Encephalopathy (HIE), Sarnat II or III  
f. Intra-ventricular Hemorrhage (IVH), Grade III or IV 
g. Peri-ventricular Leukomalacia (PVL) 
h. Extra-Corporeal Membrane Oxygenation (ECMO) or inhaled Nitrous Oxide (iNO) or  
    High-Frequency Oscillatory (HFO) or Jet (HFJ) ventilation  
i.  Hyperbilirubinemia >=400uM OR meeting any standard criteria for exchange  
j.  Serologically proven cytomegalovirus (CMV) infection  
k. Other proven perinatal TORCHES infection (toxoplasmosis, rubella, herpes, syphilis)  
l.  Serologically proven meningitis, irrespective of the pathogen  
m. Familial Permanent Childhood Hearing Impairment  
n. Craniofacial anomaly  
o. Other high risk indicator specified by baby's treating physician  
Infant (0-24 months)  
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All of the above, plus:  
1. Parent/Caregiver concern about hearing/speech/language.  
2. Postnatal infections associated with sensorineural hearing loss (e.g. bacterial meningitis). 
3. Syndromes associated with progressive hearing loss (NFII, Stickler, Usher, etc). 4. 
Neurodegenerative disorders (e.g. Hunter syndrome) and sensory motor neuropathies (e.g. 
Friedreich’s ataxia, Charcot-Marie-Tooth syndrome).  
5. Head trauma sufficient to cause unconsciousness or skull fracture  
Newborns known to be at risk on any Perinatal indicator shall be screened only by AABR. 
Infants who manifest any indicator are targeted for surveillance procedures through the 
first two years. Infants with meningitis may proceed upon recovery directly to fast-tracked 
Assessment, with subsequent surveillance in the event of a normal initial Assessment.  
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Appendix D: IHP Middle Ear Analysis (MEA) Technical Criteria 
Tympanometry  
The current IHP protocol is based on discussions in 2003 with Dr Robert Margolis, 
University of Minnesota, and on normative data kindly provided by him and published later 
in JAAA.  
For infants under six months corrected age: Tympanometry shall be done using a 1kHz 
probe frequency, with repetition as necessary and feasible, to improve reliability. The key 
abnormality criterion is a compensated peak static admittance of <= 0.6 mmho, 
compensated from the negative tail at -400 daPa.  
For infants six months and over corrected age: Tympanometry shall be done using a 226 
Hz probe frequency, with repetition as necessary and feasible, to improve reliability. The 
key abnormality criterion in the age range 7-12 months is a compensated peak static 
admittance of 0.1 mmho, compensated from the positive tail at +200 daPa. From 13-18 
months, the criterion is 0.15 mmho. From 19 months on, the criterion is 0.2 mmho. 
Middle-Ear Muscle Reflexes  
Irrespective of age, acoustic reflexes shall be elicited with a 1 kHz stimulus and measured 
ipsilaterally, using a 1 kHz probe frequency. Stimulus level shall start at 90 dB and increase 
in 5 dB steps up to no greater than 100 dB. Note that for a given nominal level, real-ear SPLs 
in young infants may be up to 20 dB greater than in adults. Reflex presence is defined by a 
clear, negative deflection, repeatable at any stimulus level.  
Comments  
Tympanometry criteria are set at the 5th percentiles of age-specific normative distributions. 
In the case of double peaks, the large peak is used. Admittance change without development 
of a genuine peak is abnormal regardless of change size. Caution is required in applying 
these criteria to young neonates, in whom canal wall collapse may lead to steep negative 
tails. The clinical utility of other measures such as peak pressure, width and gradient is 
unclear in infants. Reported 90% range boundaries for TPP are from approximately (-150 to 
-100) up to (0 to 50) daPa.  
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Appendix E: Types of Assessment and Timing of Initial Assessments 
1.  Types of Assessment 
Assessments are ABR-based or Behaviour-based. The latter includes Visual Reinforcement 
Audiometry (VRA), conditioned play audiometry (CPA), or conventional audiometry. The 
choice of approach is at the discretion of the IHP audiologist, taking account of the 
individual characteristics of the child and the context and purpose of the Assessment.  
Assessment may be of Initial, Follow-up or Surveillance types. This protocol shall apply to 
all types, but test selection and direction of testing effort in the context of follow-up is at the 
discretion of the IHP audiologist. For Initial Assessments funded by the IHP, the full 
complement of tests as specified in this protocol is mandatory. 
2.  Timing of Initial Assessments 
Where not medically contra-indicated, Initial Assessments of infants referred from IHP 
screening shall be targeted at a corrected age of 6-8 weeks. For NICU graduates after 
extended hospital stays, Initial Assessment shall be targeted within 4 weeks of discharge 
home, subject to appropriate health status. 
Initial ABR-based Assessment shall follow any abnormal result at the IHP Surveillance ABR 
targeted at 4-6 months corrected age in high-risk infants who pass the AABR screen. For 
infants at risk who refer on the screen but are normal at Assessment, at least 3 months shall 
elapse between Assessment and the next Surveillance test, which will usually be VRA-based 
at 10-12 months. Initial Assessment by other age-appropriate techniques may be indicated 
by an abnormal finding at any high-risk Surveillance event, up to and including the 30-
month family interview. See Appendix C for IHP risk indicators for permanent childhood 
hearing impairment, which govern eligibility for IHP Surveillance. 
Abnormal findings on any IHP Surveillance event shall lead to a full Assessment of the 
appropriate type, as soon as possible, even at the same visit if test conditions and 
scheduling permit. 
For any infant with a meningitis risk indicator, Assessment is indicated as soon as possible 
after recovery, if there is a referral into IHP. For this risk indicator specifically, IHP 
Screening or Surveillance testing prior to full Assessment are NOT appropriate. Special, 
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non-IHP, fast-track protocols for follow-up of meningitis may be in place locally. Optimal 
Assessment procedures and timing above and beyond the above specification are currently 
under review of evidence. 
There is accumulating evidence that specific risk indicators other than meningitis may 
warrant direct eligibility for Assessment and may render screening irrelevant or even 
inappropriate. Examples may include ear canal atresia and proven cytomegalovirus 
infection. This matter is also under evidence review. 
3.  Surveillance Assessments 
Surveillance Assessments shall be conducted on all IHP registrants who are determined as 
at risk by IHP risk indicators. They shall be conducted without regard to passing UNHS or 
determination of normality at any prior Assessment.  At a corrected age of 4-6 months, 
Surveillance Assessment shall include manual ABR measurement by air conduction at the 
IHP minimum levels for 2 kHz and 4 kHz bilaterally. DPOAE and MEA testing are 
discretional. ABR absence at any minimum level shall lead to prompt, full diagnostic 
Assessment, which may be a separate appointment or may be initiated at the Surveillance if 
test conditions and schedules permit. 
Surveillance testing at 4-6 months shall NOT be replaced by telephone interview, except in 
cases of persistent inability or refusal to attend for testing. AABR screening shall NOT be 
substituted for manual ABR testing. 
At a corrected age of 10-12 months, Surveillance Assessment shall include VRA Minimum 
Response Level (MRL) determination at 2 kHz and 4 kHz bilaterally. DPOAE and MEA 
testing are discretional. Any MRL greater than the IHP minimum level shall lead to prompt, 
full diagnostic Assessment, which may be a separate appointment or may be initiated at the 
Surveillance, if test conditions and schedules permit. 
Surveillance testing at 10-12 months shall NOT be replaced by telephone interview, except 
in cases of persistent inability or refusal to attend for testing. 
Families shall be contacted at a corrected age of as close as possible to 18 months and 
administered appropriate questioning about auditory responsiveness and early language 
milestones. Any substantive, questionable finding or parental concern shall lead to prompt, 
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full diagnostic Assessment. 
Families shall be contacted at a corrected age of as close as possible to 30 months and 
administered appropriate questioning about auditory responsiveness and early language 
milestones. Any substantive, questionable finding or parental concern shall lead to prompt, 
full diagnostic Assessment. 
Infants who pass all the above Surveillance events shall be discharged from the IHP. They 
may be re-admitted to the IHP only if audiometry outside of IHP and by an audiologist 
registered with CASLPO has identified probable PCHI. Such audiometry shall not constitute 
IHP Assessment, but shall be deemed to establish sufficient PCHI risk to justify referral into 
the IHP for diagnostic Assessment. 
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Appendix F: Ontario IHP Regions 
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Appendix G: Ontario IHP Schematic Flowchart Protocol 
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Appendix H: Hearing Loss Type Tables in Detail 
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Appendix I: Severity of Hearing Loss by Referral Group Tables (PTA3 and PTA4) 
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